TSS:Rfhg 196667.1

Basic information about the TSS

---

TSS ID: rfhg_196667.1 Species: human Chr: chr17		Start: 59707964 End: 59708004 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2948186,EH38E1874947)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK293664:-242 GeneID: 81671 HGNC/MGI_ID: HGNC:29559 UniProt_ID: B4DEJ9 Nearer transcript ids and distances: ENST00000591315.5:-246 ENST00000592106.5:-258 ENST00000589823.6:-268 ENST00000588131.1:-293 AF214006:-296 AK294854:-299 ENST00000587945.1:-300 ENST00000262291.9:-310 NM_001329402.2:-310 NM_001329400.2:-310 NM_001329401.2:-310 NM_001329399.2:-310 NM_001329398.2:-310 NM_001329396.2:-310 NM_001329397.2:-310 NM_030938.5:-310 NM_001329395.2:-310 NM_001329394.2:-310 AK024969:-312 ENST00000585847.5:-313 BC009758:-313 ENST00000586245.5:-314 AK301254:-314 ENST00000593168.5:-316 AK293578:-316 AL136711:-322 view more...

Gene_name: vacuole membrane protein 1 Gene_symbol: VMP1 Gene_synonyms: EPG3 TANGO5 Gene_source: HGNC:29559

TATA-Box annotation

---

Distance to TSS:	330
Nearest PromoterID:	NM_001329400
Entrez ID:	81671
Nearest Unigene:	Hs.444569
Nearest Refseq:	NM_030938
Nearest Ensembl:	ENSG00000062716
Gene Name:	vacuole membrane protein 1
Gene Alias:	EPG3|TANGO5|TMEM49
Gene Type:	protein-coding
CpG%:	0.075000
GC%:	0.609756
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VMP1 p2@VMP1 p3@VMP1 p4@VMP1 p7@VMP1 p8@VMP1 p9@VMP1 p10@VMP1
Sample		p1@VMP1	p2@VMP1	p3@VMP1	p4@VMP1	p7@VMP1	p8@VMP1	p9@VMP1	p10@VMP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	51.43	0.39	0.39	0.39	3.31	1.36	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	50.98	0.00	0.20	0.20	3.03	1.01	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	49.38	0.00	0.00	0.00	2.70	1.16	0.77	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	50.73	0.00	0.21	0.21	3.74	1.25	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	52.19	0.22	0.45	0.22	2.02	0.90	1.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	49.23	0.19	0.00	0.39	2.91	1.16	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	70.59	0.22	0.44	0.00	2.18	0.87	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	60.07	0.00	0.00	0.00	5.33	0.48	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	51.08	0.21	0.00	0.00	1.50	1.07	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	42.31	0.00	0.00	0.00	3.48	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.15	0.40	0.40	0.40	0.40	0.00	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	40.25	0.00	0.00	0.81	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.66	0.16	0.00	0.00	63.19	29.98	20.15	13.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.77	0.00	0.00	0.15	86.45	27.06	23.91	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.47	0.00	0.00	0.00	53.57	21.08	20.20	12.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.62	0.00	0.00	0.00	67.90	27.92	19.62	12.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.68	0.00	0.00	0.00	63.77	19.22	18.13	12.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	24.47	0.00	0.00	0.00	63.27	26.15	15.19	12.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	0.00	0.00	0.00	77.84	18.13	19.73	11.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.57	0.15	0.00	0.00	73.57	20.16	22.72	13.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	30.34	0.00	0.13	0.00	69.10	25.93	20.72	12.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.76	0.17	0.00	0.00	72.67	24.17	30.73	18.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.57	0.00	0.00	0.00	67.08	23.14	19.91	11.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.15	0.00	0.00	0.00	64.55	26.45	19.66	12.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.54	0.00	0.00	0.00	74.30	25.03	27.86	20.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	0.00	0.00	0.00	59.82	21.21	13.29	12.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.78	0.00	0.00	0.00	87.36	28.57	28.02	19.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	34.89	0.00	0.24	0.00	149.23	51.39	71.90	55.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.17	0.00	0.00	0.00	107.57	38.44	50.88	38.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	34.38	0.00	0.00	0.18	182.23	53.38	84.87	57.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	28.05	0.00	0.00	0.00	235.09	81.02	103.63	69.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.66	0.00	0.00	0.00	217.26	79.52	102.97	66.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	26.59	0.42	0.00	0.00	215.25	86.31	91.16	69.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.05	0.00	0.00	0.33	413.17	99.62	166.26	112.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.54	0.00	0.00	0.00	347.61	106.58	143.23	92.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.98	0.00	0.19	0.19	302.19	91.02	124.75	75.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.56	0.00	0.00	0.00	365.64	95.45	131.42	77.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.83	0.40	0.00	0.00	322.98	81.00	120.69	68.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.76	0.00	0.00	0.00	264.97	87.78	94.81	59.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.25	0.00	0.00	0.00	194.21	72.74	76.82	43.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.76	0.00	0.00	0.00	188.68	61.17	71.05	39.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.21	0.00	0.00	0.15	293.96	74.95	96.62	57.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.84	0.00	0.00	0.00	273.95	78.45	101.86	60.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.27	0.17	0.00	0.00	229.55	77.80	85.67	50.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	44.57	0.00	0.00	0.20	241.13	67.66	90.35	56.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.59	0.00	0.00	0.23	219.85	82.59	83.99	49.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.79	0.00	0.00	0.00	194.80	67.65	78.93	44.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.98	0.00	0.00	0.30	181.51	59.91	78.39	40.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	33.99	0.00	0.00	0.00	208.97	76.36	81.63	44.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.16	0.00	0.20	0.00	235.76	68.34	87.35	47.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.53	0.20	0.00	0.00	499.68	112.31	98.58	83.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	46.25	0.00	0.22	0.00	414.73	106.96	97.62	71.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	321.82	0.00	0.00	0.00	2560.57	8269.38	489.73	419.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.65	0.00	0.00	0.00	308.37	75.94	75.23	48.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.50	0.00	0.00	0.00	400.31	82.18	95.11	72.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	162.75	0.84	0.84	0.00	880.05	625.01	232.39	161.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	62.00	0.92	0.46	0.00	665.90	152.47	154.76	118.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	30.47	0.00	0.00	0.00	542.56	102.42	102.09	82.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	24.73	0.00	0.00	0.00	282.63	92.82	66.48	49.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	59.72	0.31	0.00	0.31	1024.09	281.33	240.46	165.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	28.91	0.00	0.00	0.00	321.50	80.38	62.75	53.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.43	0.00	0.00	0.56	299.46	84.12	60.00	51.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	85.98	0.00	0.00	0.00	936.26	485.65	195.85	140.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	40.77	0.00	0.00	0.00	634.69	124.35	122.66	90.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.32	0.32	0.00	0.00	574.46	112.42	94.23	84.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.53	0.00	0.00	0.00	335.46	88.74	64.96	48.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	0.00	0.00	0.00	1745.70	7176.79	339.44	161.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	386.98	0.00	0.00	0.00	1595.29	3617.05	355.39	221.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.71	0.00	0.00	0.00	239.86	58.01	39.00	18.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	0.00	0.00	0.00	305.46	46.61	41.16	19.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.49	0.00	0.00	0.00	282.41	44.10	31.43	29.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	43.39	0.00	0.00	0.00	537.85	86.44	72.20	27.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.62	0.31	0.00	0.00	459.37	73.31	46.71	36.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	32.71	0.31	0.00	0.31	261.72	51.67	34.85	18.04
Adipocyte - breast, donor1	11376-118A8	78.56	1.11	0.16	0.63	56.86	25.18	10.45	5.70
Adipocyte - breast, donor2	11327-117E4	48.45	0.48	0.48	0.16	43.64	22.94	5.78	6.58
Adipocyte - omental, donor1	11473-119C6	74.17	0.51	0.25	0.25	74.05	27.10	14.12	6.36
Adipocyte - omental, donor2	11474-119C7	54.57	0.75	0.00	0.00	82.22	8.97	8.97	3.74
Adipocyte - omental, donor3	11475-119C8	51.58	0.67	0.33	0.33	78.37	6.36	8.71	6.03
Adipocyte - perirenal, donor1	11476-119C9	54.23	0.00	0.00	0.00	86.13	5.10	14.67	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	0.00	0.00	0.00	14.29	2.20	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	55.55	0.45	0.45	0.00	9.48	3.16	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	32.67	0.35	0.00	0.35	11.30	4.69	1.56	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	60.63	0.00	0.98	0.59	125.56	51.44	30.51	11.34
Adipocyte differentiation, day04, donor2	13022-139D7	32.94	0.26	0.77	0.00	97.03	29.08	15.44	6.18
Adipocyte differentiation, day04, donor3	13025-139E1	39.86	0.84	0.84	0.56	43.21	16.45	5.58	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	43.50	1.76	1.18	0.00	53.49	15.28	6.47	3.53
Adipocyte differentiation, day08, donor1	13020-139D5	54.94	0.80	0.16	0.64	25.18	8.04	7.72	4.91
Adipocyte differentiation, day08, donor2	13023-139D8	38.09	0.00	0.65	0.32	74.56	25.17	15.49	9.36
Adipocyte differentiation, day08, donor3	13026-139E2	30.39	0.00	0.00	0.00	10.66	6.40	2.13	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	38.95	0.56	0.00	0.56	19.48	6.68	3.90	5.01
Adipocyte differentiation, day12, donor1	13021-139D6	45.75	0.83	0.83	0.42	21.21	4.16	3.74	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	38.93	0.00	0.50	0.50	50.48	19.84	10.80	5.53
Adipocyte differentiation, day12, donor3	13027-139E3	40.25	0.98	0.33	0.33	14.07	8.51	2.95	2.62
Adipocyte differentiation, day12, donor4	13030-139E6	36.23	0.61	0.00	0.30	14.31	2.44	3.65	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	34.25	0.44	0.00	0.22	50.61	11.93	4.20	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	0.00	0.00	0.00	30.84	2.15	1.43	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	19.17	2.40	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	33.46	0.00	0.00	0.00	10.07	2.52	1.80	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	0.00	0.00	0.00	3.35	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.39	0.00	0.00	0.00	8.83	4.52	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	54.12	0.80	0.00	0.23	45.08	11.79	8.24	3.09
Anulus Pulposus Cell, donor2	11463-119B5	31.35	0.24	0.00	0.00	29.88	0.73	3.67	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	36.84	0.00	0.00	0.00	102.44	34.15	7.64	4.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.60	0.00	0.00	0.43	85.53	24.31	7.81	3.91
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	0.00	0.00	0.00	85.61	47.09	6.42	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	40.65	0.00	0.00	0.60	101.93	30.19	7.77	4.78
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	0.00	0.00	0.00	142.91	22.76	7.59	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	32.34	0.00	0.00	0.66	84.49	29.70	7.92	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.11	0.00	0.32	0.32	89.67	22.42	6.82	4.55
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	41.75	0.00	0.49	0.00	120.87	42.72	7.77	3.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.94	0.00	0.00	0.00	127.09	33.26	8.31	5.34
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	49.72	0.00	0.00	0.00	155.93	44.44	11.68	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.01	0.73	0.00	0.00	138.60	35.56	7.26	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	1.25	0.00	0.00	195.59	52.66	3.76	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	57.00	0.16	0.00	0.00	91.43	29.16	10.21	4.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	0.00	0.00	0.00	116.01	36.85	6.82	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.31	0.15	0.30	0.15	188.04	30.16	20.21	6.48
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.29	0.54	0.00	0.00	86.80	27.33	9.11	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.09	0.00	0.19	0.38	98.06	21.73	10.20	6.99
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.54	0.00	0.00	0.00	107.45	21.12	9.36	6.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	31.21	0.00	0.00	0.98	112.18	27.31	4.88	10.73
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	42.46	0.17	0.00	0.33	118.59	31.02	13.77	8.29
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	0.00	0.00	0.00	146.49	30.02	14.41	8.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00	0.00	0.00	155.77	31.86	3.54	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	42.02	0.00	0.17	0.17	106.01	22.81	9.61	7.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00	142.63	37.75	12.58	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	43.69	0.00	0.00	0.00	128.64	35.44	13.59	13.11
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	44.78	0.00	0.00	0.38	142.67	31.11	15.94	10.25
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	0.00	0.00	0.00	132.04	35.13	15.75	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.75	0.00	0.57	0.00	124.27	44.46	14.82	9.12
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	37.20	0.00	0.00	0.00	122.49	27.15	15.82	7.48
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	27.87	0.00	0.00	0.52	109.69	32.26	10.84	9.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.41	0.00	0.00	0.47	79.77	25.34	4.22	4.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.48	0.00	0.00	0.32	97.11	25.40	10.29	4.18
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	0.00	0.00	0.00	111.30	24.97	10.70	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	36.27	0.00	0.00	0.58	77.80	23.98	2.34	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.52	0.00	0.00	0.00	110.79	21.38	8.73	4.52
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	0.00	0.00	0.00	130.68	30.89	14.26	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	45.26	0.00	0.00	0.00	158.16	33.56	8.14	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	43.81	0.25	0.25	0.00	197.38	35.40	14.26	5.35
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	30.50	0.00	0.00	0.00	137.87	22.87	3.18	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	32.37	0.00	0.00	0.43	116.08	37.97	4.75	4.32
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	40.86	0.42	0.00	0.21	147.76	37.05	9.31	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.58	0.00	0.00	0.00	124.98	31.61	6.96	5.22
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	42.51	0.00	0.00	1.89	138.88	36.84	9.45	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.58	0.34	0.00	0.00	129.01	27.46	10.34	4.24
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	0.00	0.00	0.00	132.03	27.80	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	0.00	0.00	2.11	128.87	12.68	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	43.10	0.21	0.00	0.00	123.93	25.94	9.65	4.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.85	0.00	0.00	0.00	141.99	34.29	10.23	6.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	0.00	0.00	0.00	107.89	32.80	6.56	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.06	0.00	0.00	0.00	127.35	22.99	13.10	5.52
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	0.00	0.00	160.67	28.05	12.75	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	33.81	0.00	0.25	0.00	142.88	20.59	19.83	9.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	38.40	0.00	0.00	0.00	121.80	27.04	10.73	5.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.23	0.00	0.00	0.00	115.97	32.44	8.26	3.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	47.80	0.00	0.48	0.48	136.23	49.71	14.34	6.21
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.92	0.22	0.00	0.22	128.17	29.49	14.19	5.54
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	0.00	0.00	0.00	173.94	41.20	15.26	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	39.88	1.11	0.00	0.00	94.16	32.68	10.52	5.54
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.04	0.00	0.26	0.00	103.00	23.04	8.74	6.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	25.80	0.73	0.36	0.00	127.21	34.89	10.18	4.72
Astrocyte - cerebellum, donor1	11500-119F6	31.20	0.00	0.00	0.12	74.55	5.04	17.81	5.28
Astrocyte - cerebellum, donor2	11580-120F5	19.34	0.17	0.00	0.17	48.27	3.59	4.28	1.88
Astrocyte - cerebellum, donor3	11661-122F5	9.86	0.42	0.00	0.00	21.39	12.58	5.87	3.15
Astrocyte - cerebral cortex, donor1	11235-116D2	61.35	0.35	0.35	0.35	67.28	38.34	29.28	9.41
Astrocyte - cerebral cortex, donor2	11316-117D2	38.50	0.00	0.16	0.32	84.28	53.55	13.59	5.34
Astrocyte - cerebral cortex, donor3	11392-118C6	46.24	0.00	0.15	0.15	83.38	26.85	17.00	8.65
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	37.85	0.69	0.34	0.34	84.41	38.30	6.42	3.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.60	1.25	0.50	0.25	85.82	34.33	6.51	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	44.38	0.91	0.23	0.11	72.26	30.95	6.60	4.55
Basophils, donor1	12241-129G9	83.17	7.32	8.89	1.05	50.48	8.63	3.14	1.05
Basophils, donor2	12242-129H1	82.26	14.79	8.66	1.44	107.88	13.35	7.94	0.72
Basophils, donor3	12243-129H2	89.52	3.82	1.76	1.03	46.01	10.58	4.56	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	11.21	0.00	0.00	0.43	17.25	3.67	1.08	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	0.00	0.46	0.00	39.78	2.29	1.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	78.91	7.17	14.35	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	0.00	0.63	0.00	41.43	1.26	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	34.10	0.00	0.21	0.21	23.50	2.70	1.25	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	26.02	0.00	0.23	0.23	84.29	2.76	1.61	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	30.95	0.00	0.18	0.00	37.79	7.02	4.32	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.67	3.19	1.13	1.03	14.22	4.74	1.75	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	49.14	1.40	0.47	0.47	82.91	17.93	6.52	3.96
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	53.40	1.28	0.96	1.92	28.46	5.12	5.44	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	108.20	3.94	2.82	1.69	225.99	52.97	34.38	5.07
CD14+ Monocytes, donor2	11305-117B9	94.66	4.45	2.23	1.30	131.41	50.30	7.61	3.34
CD14+ Monocytes, donor3	11381-118B4	90.67	1.54	1.76	1.54	138.97	35.13	10.32	4.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	133.88	1.13	0.85	0.85	63.97	24.91	13.02	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	119.03	1.90	2.27	0.38	77.71	26.16	15.54	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	138.73	0.99	1.31	0.99	75.61	16.44	19.72	4.27
CD14+ monocytes - mock treated, donor1	11863-125A9	161.32	1.30	2.17	3.32	120.41	37.15	9.54	8.09
CD14+ monocytes - mock treated, donor2	11873-125C1	106.52	1.81	3.32	0.91	91.73	17.80	6.94	3.62
CD14+ monocytes - mock treated, donor3	11883-125D2	150.90	2.37	6.16	2.61	78.65	11.13	7.34	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	85.37	1.67	1.84	0.84	221.80	57.92	14.90	7.70
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	98.26	1.10	1.93	1.38	192.38	40.02	12.14	4.69
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	121.24	1.49	2.48	1.74	332.22	48.35	24.05	11.90
CD14+ monocytes - treated with BCG, donor1	11860-125A6	93.40	1.17	2.35	0.98	420.97	174.46	22.52	9.01
CD14+ monocytes - treated with BCG, donor2	11870-125B7	97.39	1.07	1.07	1.07	265.83	109.68	16.38	7.66
CD14+ monocytes - treated with BCG, donor3	11880-125C8	180.42	1.52	4.57	1.74	729.71	92.71	58.32	18.28
CD14+ monocytes - treated with Candida, donor1	11868-125B5	92.48	2.11	1.64	1.17	500.56	139.07	25.29	12.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	108.77	2.11	1.58	1.06	569.74	134.65	33.27	15.31
CD14+ monocytes - treated with Candida, donor3	11888-125D7	136.45	1.11	6.66	1.11	489.23	96.51	44.37	19.97
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	102.49	2.08	1.78	1.49	148.00	47.15	8.48	5.95
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	111.95	1.20	1.40	1.00	130.70	24.34	9.98	5.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	203.20	2.50	2.71	1.87	254.21	21.03	29.15	7.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	129.03	0.46	1.37	1.37	792.74	234.05	34.78	14.18
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	123.73	2.26	0.90	0.68	570.71	45.47	37.32	10.63
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	133.12	1.31	1.75	0.87	684.81	121.77	38.85	15.71
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	98.72	1.34	1.61	1.08	219.23	68.32	15.87	9.41
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	119.16	1.05	1.22	1.05	214.41	108.17	15.18	6.46
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	135.50	2.10	1.68	4.21	303.83	78.69	21.46	13.05
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	95.53	0.92	0.73	1.29	279.98	76.97	11.76	5.51
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	102.86	1.41	1.06	1.41	275.47	39.45	9.16	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	114.95	0.88	2.19	0.88	320.27	68.44	15.36	3.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	86.32	1.39	2.27	1.74	520.16	230.35	25.81	10.29
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	87.72	2.23	1.86	1.86	476.12	163.17	23.42	8.92
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	170.28	2.59	3.66	2.16	766.49	109.71	65.31	22.20
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	93.77	0.00	2.87	0.82	268.21	56.51	8.19	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	115.67	0.93	2.55	0.70	361.84	28.05	14.37	4.17
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	148.47	1.16	2.09	1.86	538.69	46.40	32.01	7.66
CD14+CD16+ Monocytes, donor1	11789-124B7	183.53	5.45	10.68	1.53	34.22	2.83	2.18	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	188.49	3.00	3.93	5.77	29.11	3.70	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	185.42	4.33	4.98	3.90	34.44	3.68	3.68	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	284.97	4.98	7.01	5.14	60.11	10.43	7.63	2.65
CD14+CD16- Monocytes, donor2	11799-124C8	265.81	4.72	2.79	2.97	62.70	10.48	8.91	1.92
CD14+CD16- Monocytes, donor3	11910-125G2	255.52	3.79	10.03	5.80	99.44	9.59	11.59	5.13
CD14-CD16+ Monocytes, donor1	11790-124B8	224.81	6.89	15.06	4.59	7.14	2.30	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	274.46	5.93	10.98	3.73	12.73	3.95	0.66	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	235.60	5.47	9.47	5.68	19.79	2.11	1.68	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	22.36	12.19	4.06	2.03	2.03	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	45.42	12.88	6.10	2.71	4.75	0.68	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	34.17	10.36	3.11	1.04	10.36	2.07	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	69.29	9.59	7.46	4.26	5.86	4.80	1.07	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	45.03	10.72	2.14	0.00	1.07	1.07	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	40.71	11.93	4.21	2.11	3.51	4.21	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	52.55	10.20	7.84	1.57	3.14	2.35	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	59.32	19.77	7.91	2.64	7.91	2.64	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	39.45	11.51	3.29	0.00	9.86	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	29.02	6.53	2.90	0.73	15.23	2.90	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	27.26	6.56	4.54	0.50	12.12	2.02	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	63.84	2.42	1.21	0.00	11.72	1.62	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	51.53	0.00	2.00	0.00	9.19	0.80	1.60	1.20
CD34+ Progenitors, donor1	11545-120B6	75.30	5.02	1.00	3.01	23.09	5.02	7.03	2.01
CD34+ Progenitors, donor2	11625-122B5	80.34	2.81	1.69	1.12	101.13	2.81	11.24	6.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	50.35	1.50	1.13	0.75	21.42	4.13	2.25	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	43.07	1.35	0.90	1.58	32.47	8.34	2.48	0.68
CD4+ T Cells, donor1	11225-116C1	50.35	16.78	7.50	2.14	33.56	11.43	1.43	1.07
CD4+ T Cells, donor2	11306-117C1	39.19	17.15	5.51	1.22	61.24	33.07	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	35.38	15.25	7.32	0.61	164.09	39.04	9.15	4.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	50.79	12.00	4.08	1.79	252.94	56.15	13.53	6.89
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	41.10	9.88	4.04	1.35	383.84	63.11	18.19	8.76
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.21	11.50	2.59	0.86	339.20	44.84	22.71	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	36.03	23.23	9.96	0.95	19.44	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	56.89	23.88	8.43	1.40	23.88	7.02	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	29.67	9.89	0.00	9.89	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	49.71	10.98	3.03	1.59	301.89	67.78	12.28	5.49
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.69	4.91	2.37	0.34	355.87	94.73	14.40	9.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.18	5.64	1.13	0.81	390.28	100.75	15.64	7.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	37.66	16.14	8.07	0.45	55.14	13.90	0.90	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.13	17.47	9.78	1.40	63.59	10.13	6.29	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	42.24	21.12	3.08	1.76	156.19	13.64	4.40	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.85	11.38	4.22	2.95	55.66	8.01	2.95	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.39	4.16	1.87	1.04	75.63	19.32	2.70	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	24.73	3.68	4.34	0.67	64.15	14.03	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.16	23.11	6.25	2.18	9.79	2.45	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	24.12	6.97	1.61	10.72	2.14	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	23.31	3.59	0.00	8.97	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.25	14.09	3.71	2.04	131.28	26.15	6.12	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.99	9.10	5.63	1.08	161.16	26.21	8.45	4.12
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	36.36	7.99	4.41	1.68	228.01	32.57	7.78	3.15
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.45	15.67	8.60	2.02	46.01	11.12	5.06	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.96	16.90	5.20	2.60	63.69	13.00	3.90	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.07	22.66	9.15	1.31	117.23	10.46	6.54	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	30.19	5.94	1.98	39.59	6.93	2.97	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	36.00	7.39	0.92	18.46	3.69	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	39.08	27.92	5.58	4.19	15.35	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	79.48	32.68	6.92	6.37	26.86	2.22	3.05	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	67.97	36.32	8.34	1.23	28.47	0.98	2.45	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	70.84	21.56	10.78	6.16	61.60	7.70	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	64.82	24.71	12.18	4.30	36.17	11.10	3.58	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	49.86	33.24	15.23	4.15	33.24	4.15	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	65.81	15.39	7.20	2.62	47.80	14.08	3.93	0.33
CD8+ T Cells, donor2	11307-117C2	53.69	9.76	7.88	1.50	95.36	39.04	4.51	1.88
CD8+ T Cells, donor3	11383-118B6	49.24	11.36	9.59	1.26	70.44	14.39	2.52	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.94	0.46	0.23	0.23	61.48	19.96	3.67	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.25	0.24	0.00	0.24	65.90	19.65	2.88	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.07	1.09	1.37	0.27	94.66	21.61	5.20	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	27.62	0.60	0.30	0.00	123.69	27.92	12.91	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.64	0.72	0.24	0.00	87.35	20.40	4.56	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.97	0.23	0.23	0.00	78.90	18.87	3.87	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.55	0.00	0.22	0.00	57.80	19.77	3.48	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	28.69	0.00	0.53	0.00	72.38	18.16	4.74	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.56	0.47	0.00	0.23	64.96	17.82	1.88	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.98	0.60	0.60	0.30	80.90	28.07	4.53	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.66	1.45	0.00	0.00	85.99	22.37	2.32	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.17	0.53	0.00	0.80	74.87	16.79	3.20	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.32	0.44	0.44	0.88	70.48	22.33	7.00	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	18.22	0.46	0.00	0.00	71.05	17.76	5.01	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	0.75	0.75	0.00	87.27	26.85	5.97	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	0.00	0.36	0.72	86.80	24.49	7.56	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.28	0.29	0.58	0.00	86.60	35.10	4.03	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.09	0.24	0.00	0.00	81.55	26.63	4.71	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.01	0.00	0.63	0.63	84.93	21.55	3.17	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.76	0.00	0.00	0.31	81.50	23.37	3.38	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.61	0.32	0.32	0.00	84.63	17.63	4.81	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	24.86	0.38	0.76	0.38	89.11	24.86	2.29	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	1.18	0.00	0.00	83.94	19.31	2.36	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	0.00	0.00	0.00	91.53	21.94	5.29	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	0.00	0.80	0.00	267.38	70.66	8.83	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	1.40	0.00	0.00	258.09	63.65	11.19	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	1.00	2.00	0.00	261.46	58.10	13.02	4.01
Cardiac Myocyte, donor1	11525-119I4	62.14	0.00	0.00	0.00	164.50	21.93	12.79	16.45
Cardiac Myocyte, donor2	11605-120I3	38.54	0.49	0.00	0.00	56.33	26.68	6.92	5.43
Cardiac Myocyte, donor3	11686-122I3	49.46	0.11	0.21	0.21	9.47	3.16	1.26	0.84
Chondrocyte - de diff, donor1	11261-116G1	44.37	0.35	0.69	0.69	134.16	7.28	6.59	2.08
Chondrocyte - de diff, donor2	11338-117F6	40.16	0.71	0.36	0.00	43.36	13.15	11.02	2.49
Chondrocyte - de diff, donor3	11410-118E6	27.19	0.57	0.34	0.34	36.41	15.36	3.07	2.16
Chondrocyte - re diff, donor2	11339-117F7	132.50	0.00	0.00	0.90	85.94	20.59	6.27	5.37
Chondrocyte - re diff, donor3	11411-118E7	34.37	0.40	0.40	0.00	42.06	16.18	7.68	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	52.90	0.46	0.11	0.23	150.91	65.99	46.13	27.54
Ciliary Epithelial Cells, donor2	11323-117D9	38.05	0.00	0.00	0.00	99.19	57.29	20.52	16.25
Ciliary Epithelial Cells, donor3	11399-118D4	38.50	0.09	0.00	0.00	173.63	54.16	35.66	21.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.47	0.55	1.01	0.73	58.32	22.01	6.51	2.20
Corneal Epithelial Cells, donor1	11526-119I5	6.81	0.00	0.00	0.00	12.52	1.10	1.54	0.22
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	0.00	0.00	9.10	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.99	0.00	0.00	0.00	10.99	6.14	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	51.51	0.66	0.50	0.83	119.36	21.63	13.04	3.63
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.62	0.32	1.26	0.00	76.01	26.81	8.20	3.78
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	0.00	0.00	0.00	65.56	10.35	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.12	0.22	0.00	0.65	76.78	27.75	5.40	3.46
Dendritic Cells - plasmacytoid, donor1	11228-116C4	79.26	0.00	0.68	0.00	7.17	4.10	2.05	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	79.00	0.65	0.00	1.31	5.22	1.31	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	88.56	1.45	0.00	0.97	4.36	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.70	0.00	0.17	0.83	43.03	18.34	2.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	35.21	0.59	0.59	0.00	20.54	3.52	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	35.07	0.00	0.00	0.57	50.90	9.33	4.52	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	27.13	0.00	0.39	0.00	34.21	2.36	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	28.51	0.29	0.58	0.29	20.94	2.62	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	28.47	0.00	0.00	0.00	14.59	6.35	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	47.33	0.00	0.35	0.18	22.79	5.08	1.23	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	37.90	1.33	0.00	0.89	26.82	9.97	2.66	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	43.81	0.91	1.22	0.91	34.38	12.17	6.09	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	60.61	1.69	0.28	1.97	40.03	13.25	7.05	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	35.95	0.59	0.00	0.30	40.41	1.49	3.86	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	67.69	1.56	0.52	0.52	36.45	7.29	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.99	0.43	0.14	0.28	21.69	7.09	1.42	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	46.41	0.00	1.20	0.80	82.82	1.20	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	37.74	0.00	0.00	0.52	20.44	11.53	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.64	0.25	0.37	0.25	54.54	15.28	2.48	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.20	0.43	0.22	0.22	18.68	7.17	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	34.56	0.37	0.37	0.37	22.35	4.89	1.10	0.37
Endothelial Cells - Vein, donor1	11267-116G7	35.26	0.00	0.00	0.00	29.58	4.55	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	43.31	0.70	0.70	0.00	30.73	3.49	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	37.37	0.16	0.00	0.31	26.53	8.95	0.63	0.00
Eosinophils, donor1	12244-129H3	60.99	30.49	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	716.21	105.62	207.93	105.62	8.25	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	823.94	110.57	242.54	96.30	7.13	3.57	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.55	0.00	0.00	0.00	15.15	4.15	1.95	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	16.64	0.00	2.08	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	97.61	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	45.98	0.41	0.00	0.00	78.00	24.63	4.11	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.60	0.11	0.00	0.00	3.28	0.44	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.63	0.00	0.00	0.00	5.09	0.43	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	65.73	0.00	0.24	0.36	73.37	21.95	4.12	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	78.47	0.55	0.00	0.41	556.53	110.95	61.82	14.33
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.54	0.32	0.11	0.11	47.88	20.67	5.17	2.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	87.48	0.53	0.00	0.53	345.70	15.81	21.08	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.55	0.00	1.00	0.00	77.07	19.93	4.32	1.99
Fibroblast - Cardiac, donor1	11268-116G8	42.19	0.00	0.45	0.00	41.28	12.70	4.99	3.63
Fibroblast - Cardiac, donor2	11345-117G4	46.23	0.00	0.00	0.00	40.93	7.58	6.06	0.76
Fibroblast - Cardiac, donor3	11417-118F4	28.70	0.16	0.16	0.16	23.18	6.31	3.47	0.95
Fibroblast - Cardiac, donor4	11452-119A3	47.89	0.00	0.30	0.30	44.25	16.97	9.09	3.33
Fibroblast - Cardiac, donor5	11456-119A7	55.71	0.00	0.25	0.25	77.16	6.60	4.95	4.70
Fibroblast - Cardiac, donor6	11460-119B2	44.87	0.45	0.00	0.00	68.98	5.61	4.85	3.64
Fibroblast - Choroid Plexus, donor1	11492-119E7	56.01	0.80	0.27	0.54	31.22	2.41	7.24	2.28
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.06	0.43	0.00	0.00	49.61	17.69	12.51	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	52.73	1.46	0.00	0.00	101.07	42.48	13.18	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	19.60	0.23	0.00	0.00	13.84	2.31	2.31	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	46.81	0.51	0.34	0.68	45.45	17.13	10.85	6.44
Fibroblast - Dermal, donor1	11269-116G9	21.60	0.00	0.00	0.00	19.02	4.46	3.29	0.23
Fibroblast - Dermal, donor2	11346-117G5	46.70	0.00	0.94	0.00	19.81	3.30	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	29.62	0.00	0.00	0.12	15.72	4.35	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	37.53	0.00	0.00	0.00	46.69	4.75	1.13	0.57
Fibroblast - Dermal, donor5	11454-119A5	44.66	0.00	0.35	0.00	49.02	3.84	1.57	1.22
Fibroblast - Dermal, donor6	11458-119A9	43.69	0.16	0.16	0.00	75.20	6.50	3.09	0.81
Fibroblast - Gingival, donor1	11237-116D4	55.39	0.21	0.21	0.42	22.28	10.20	3.75	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	48.21	0.26	0.00	0.00	32.49	6.81	2.36	1.05
Fibroblast - Gingival, donor2	11318-117D4	40.59	0.40	0.13	0.13	34.40	15.68	1.84	1.05
Fibroblast - Gingival, donor3	11394-118C8	38.96	0.10	0.00	0.19	19.72	8.61	2.61	1.84
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	0.00	0.00	0.00	21.82	12.47	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.14	0.18	0.35	0.18	24.14	11.10	1.94	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	44.90	0.31	0.16	0.47	43.03	8.11	3.12	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.02	0.00	0.14	0.00	73.29	10.68	2.30	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.17	0.35	0.00	0.00	89.28	13.76	8.12	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	40.07	0.15	0.15	0.15	103.10	16.82	7.02	2.49
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	39.95	0.00	0.00	0.14	49.91	8.18	2.86	2.18
Fibroblast - Gingival, donor8 (control)	11926-125H9	41.79	0.22	0.11	0.11	92.47	11.52	4.39	2.74
Fibroblast - Gingival, donor9 (control)	11927-125I1	43.14	0.44	0.29	0.15	28.32	5.58	4.55	4.84
Fibroblast - Lung, donor1	11270-116H1	20.39	0.00	0.00	1.36	32.62	9.52	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	0.00	0.00	0.00	29.84	13.43	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	27.86	0.00	0.00	0.21	10.97	2.32	0.84	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	23.32	0.00	0.00	0.00	31.65	0.00	6.66	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	0.00	0.00	0.00	8.39	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.00	0.00	0.00	12.87	4.20	1.96	1.40
Fibroblast - Mammary, donor1	11540-120B1	53.59	0.00	0.00	0.41	41.81	6.09	4.87	1.22
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	19.97	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	0.00	0.00	23.83	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	65.56	0.39	0.39	0.19	44.42	19.40	2.91	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	44.14	0.30	0.00	0.30	38.53	22.60	2.12	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	60.28	0.31	0.61	0.31	30.29	10.71	3.37	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.54	0.00	0.00	0.38	79.00	14.12	3.43	4.20
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.08	0.00	0.00	0.00	58.86	28.89	3.24	2.97
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	29.46	0.12	0.12	0.00	26.21	8.00	2.90	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	81.79	0.00	0.22	0.33	33.93	9.73	2.43	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	42.47	0.20	0.00	0.00	33.32	6.91	4.47	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	0.67	0.00	0.00	17.37	4.68	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	27.68	0.00	0.00	0.00	14.63	8.70	0.79	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	84.14	0.79	0.40	0.60	311.76	10.72	15.28	5.36
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	46.71	0.00	0.18	0.18	60.57	13.32	15.10	4.09
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	51.05	0.00	0.00	0.79	53.80	11.43	7.29	3.35
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	97.48	0.00	0.00	0.00	317.70	13.84	12.03	5.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	53.00	0.11	0.22	0.00	74.16	3.89	5.29	3.56
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	53.15	0.51	0.25	0.51	357.85	25.56	29.86	5.82
Fibroblast - skin normal, donor1	11553-120C5	55.13	0.66	0.16	0.00	56.61	11.98	10.83	4.59
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	133.34	0.20	0.00	0.00	527.13	123.91	32.48	7.62
Fibroblast - skin normal, donor2	11561-120D4	65.20	0.30	0.10	0.20	157.42	6.53	9.44	4.22
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	69.82	0.00	0.30	0.30	389.28	18.74	14.81	3.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	51.45	0.17	0.08	0.08	60.06	18.72	10.02	4.97
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	63.42	0.00	0.17	0.00	55.05	3.25	10.94	7.01
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	92.95	0.66	0.33	0.66	469.00	20.03	14.45	11.82
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	64.98	0.32	0.00	0.11	86.82	4.79	6.71	2.88
Fibroblast - skin walker warburg, donor1	11554-120C6	56.85	0.17	0.51	0.17	56.85	12.15	6.07	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	55.04	0.00	0.16	0.00	12.23	2.82	1.25	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	0.00	0.00	0.00	132.96	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	48.81	0.00	0.00	0.87	58.39	7.84	3.49	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	54.95	0.17	0.17	0.00	86.68	20.63	11.79	2.77
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	70.79	0.00	0.52	0.26	90.82	23.42	10.41	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	50.34	0.00	0.00	0.00	81.51	23.00	14.56	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	39.81	0.77	0.77	0.00	9.95	5.36	2.30	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.90	0.64	0.64	0.00	21.69	5.74	7.66	6.38
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	61.05	0.00	0.00	0.29	136.93	29.95	14.26	11.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	44.12	0.28	0.00	0.00	8.55	2.48	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.53	0.68	0.00	0.00	35.62	6.85	8.68	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	45.97	0.20	0.40	0.20	85.00	16.25	8.32	7.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	36.21	0.00	0.00	0.00	13.48	2.11	2.38	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	42.40	0.00	0.33	0.00	20.22	5.22	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	47.76	1.33	0.00	1.33	167.60	26.98	15.48	11.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.51	0.14	0.14	0.42	18.94	5.65	2.69	2.40
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.83	0.25	0.25	0.00	14.04	4.93	1.60	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	42.17	0.00	0.27	0.00	13.16	7.79	1.34	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	60.34	0.25	0.25	0.37	70.37	17.35	7.19	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	64.92	0.42	0.28	0.69	67.28	19.38	7.89	4.71
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	51.03	0.41	0.20	0.20	91.08	41.88	9.35	4.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.86	0.23	0.68	0.46	56.59	27.61	7.76	5.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	55.81	0.50	0.00	0.50	58.30	12.95	7.72	5.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	46.12	0.00	0.00	0.44	44.59	24.92	7.43	3.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.98	0.30	0.30	0.30	31.62	19.21	5.91	5.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	58.81	0.16	0.32	0.16	27.34	5.25	2.70	2.54
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	49.82	0.22	0.22	0.00	20.55	10.95	2.90	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.78	0.00	0.20	0.00	16.53	6.05	2.02	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	65.65	0.17	0.00	0.00	22.56	5.94	2.88	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	76.61	0.62	0.09	0.44	47.35	15.96	8.51	4.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.50	0.10	0.21	0.21	8.22	6.76	2.39	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.44	0.17	0.51	0.00	13.15	2.73	3.93	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	60.31	0.33	0.00	0.22	9.85	2.43	1.55	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	79.37	0.25	0.25	0.00	20.80	10.90	8.99	3.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	72.89	0.41	0.41	0.00	30.83	3.68	6.33	3.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.89	0.41	0.21	0.41	17.33	10.11	3.51	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	55.69	0.35	0.12	0.00	10.61	2.65	2.19	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	50.53	0.00	0.00	0.67	10.67	4.84	2.50	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	40.56	0.22	0.00	0.22	8.38	4.63	1.98	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.11	0.37	0.00	0.25	7.63	1.84	1.35	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	49.60	0.32	0.00	0.00	11.83	4.54	1.62	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.52	0.32	0.00	0.32	7.70	5.13	2.57	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	56.38	0.19	0.00	0.09	8.53	2.56	0.95	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	52.51	0.32	0.00	0.16	6.96	5.38	1.58	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.78	0.00	0.30	0.30	22.81	9.73	3.34	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	62.30	0.42	0.10	0.31	20.38	5.96	1.99	2.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	54.01	0.00	0.22	0.22	8.34	5.05	1.54	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.33	0.00	0.00	0.28	13.75	7.86	2.24	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	62.96	0.28	0.28	0.46	30.28	7.59	4.44	2.50
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	54.82	0.27	0.00	0.53	33.16	12.03	3.48	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	50.80	0.31	0.00	0.31	30.91	14.23	3.37	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	68.91	0.13	0.13	0.00	27.46	8.29	2.33	2.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	65.33	0.00	0.00	0.81	10.30	6.51	1.08	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	56.60	0.74	0.18	0.18	40.37	22.68	6.27	3.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	54.17	0.22	0.22	0.22	37.06	19.30	5.26	3.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	78.35	0.00	0.99	0.00	14.88	9.92	3.97	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	60.55	0.40	0.00	0.40	45.91	22.29	6.73	5.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	57.30	0.40	0.00	0.20	45.19	24.01	5.04	4.44
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	166.47	0.51	0.76	1.27	9.66	6.86	2.80	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	83.01	0.80	0.60	0.20	14.53	1.00	3.18	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	54.39	0.62	0.00	0.15	18.18	4.01	2.93	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	74.26	0.61	0.00	0.00	11.25	4.30	3.68	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	40.68	0.31	0.00	0.31	21.91	6.26	8.14	5.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.91	0.57	0.00	0.28	11.87	2.83	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.66	0.00	0.00	0.46	13.37	3.69	6.00	6.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	0.00	0.00	0.00	34.65	12.37	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	49.12	0.39	0.39	0.00	13.93	4.25	3.09	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	0.00	0.00	0.00	24.07	1.60	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	0.00	1.74	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	42.64	0.00	0.00	0.00	3.58	2.28	0.33	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	57.65	0.00	0.00	0.41	4.53	2.47	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	0.00	0.00	0.00	13.33	10.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	48.66	0.56	0.00	0.00	6.15	1.68	0.56	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	44.12	0.33	0.00	0.00	1.96	0.65	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	39.43	0.00	0.00	0.00	5.03	2.52	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	48.98	0.00	0.00	0.00	2.54	0.64	0.95	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	37.70	0.00	0.00	0.00	5.43	2.38	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	33.41	0.00	0.00	0.00	0.00	6.26	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	40.66	0.00	0.57	0.00	1.15	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	36.11	0.00	0.00	0.30	3.26	0.89	0.30	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	0.00	0.00	0.00	3.39	0.00	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	46.81	0.41	0.00	0.41	5.80	1.24	0.00	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	42.11	0.23	0.00	0.00	3.91	1.38	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	0.00	0.00	0.00	10.54	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	33.06	0.00	0.00	0.38	2.69	2.31	1.92	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.66	0.65	0.33	0.00	3.26	2.61	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	0.00	0.00	0.00	4.01	2.01	1.34	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	56.25	0.00	0.39	0.39	5.39	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.47	0.68	0.34	0.00	5.48	2.74	2.05	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	0.00	0.00	0.00	17.39	2.48	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	34.45	0.00	0.00	0.47	3.30	1.89	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	47.68	0.00	0.00	0.00	5.43	4.83	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	46.80	0.00	0.00	0.00	3.56	1.53	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	44.27	0.40	0.00	0.00	4.79	2.39	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	56.74	0.49	0.49	0.00	3.95	2.47	1.97	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	0.00	0.00	0.00	8.26	5.90	1.18	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.09	0.00	0.00	0.00	2.33	5.25	2.92	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	59.25	0.00	0.00	0.00	3.95	3.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	0.00	0.00	0.00	25.43	12.72	6.78	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	35.81	0.00	0.00	0.00	15.52	5.97	4.18	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.97	0.49	0.00	0.49	12.13	3.40	3.88	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	34.24	0.00	0.00	0.00	54.78	5.71	4.57	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.55	0.00	0.00	0.00	13.31	9.98	3.33	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	0.00	0.00	1.12	29.24	5.62	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.72	0.32	0.00	0.00	156.04	55.50	18.71	12.37
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.15	0.84	0.00	0.00	47.20	19.63	7.10	3.76
Hep-2 cells mock treated, biol_rep1	11898-125E8	64.52	0.35	0.46	0.93	70.67	26.23	11.02	5.57
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.01	1.01	0.51	0.51	76.64	21.44	8.95	6.92
Hep-2 cells mock treated, biol_rep3	11900-125F1	62.11	1.14	0.91	1.14	45.27	9.78	6.37	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	62.31	0.55	0.77	0.66	86.24	33.23	14.32	8.42
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	62.32	0.21	0.43	0.86	77.58	19.56	12.68	6.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	59.20	1.08	0.43	0.43	55.11	15.07	8.40	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	65.01	0.62	0.50	0.25	27.40	10.34	3.99	3.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.10	0.34	0.00	1.03	32.42	6.18	3.95	4.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	56.07	0.96	0.64	1.28	33.32	5.45	3.20	3.20
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	0.00	0.00	0.00	3.36	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.09	0.00	0.00	0.00	30.73	7.79	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	0.00	0.00	0.00	116.33	5.29	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.58	0.00	0.00	0.35	27.51	8.11	7.05	2.82
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	0.00	0.00	0.00	28.33	11.62	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.63	0.00	0.00	0.17	35.14	6.64	1.22	2.10
Hepatocyte, donor1	11523-119I2	60.53	0.00	0.00	0.00	82.32	29.05	6.05	2.42
Hepatocyte, donor2	11603-120I1	84.03	0.00	0.00	0.00	79.72	34.47	15.08	11.85
Hepatocyte, donor3	11684-122I1	93.87	0.61	0.00	0.00	176.09	37.43	32.52	15.95
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.69	1.31	0.65	1.96	5.87	1.96	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	153.28	0.00	0.35	0.17	66.59	20.62	18.88	8.39
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.85	0.14	0.27	0.00	41.99	15.37	7.68	4.12
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	0.00	0.00	0.00	57.31	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	0.00	40.05	26.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	243.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	0.00	0.00	0.00	38.76	13.84	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	0.00	0.00	27.53	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	0.00	0.00	0.00	28.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	0.00	0.00	18.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	0.00	0.00	0.00	29.24	9.75	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	0.00	0.00	0.00	16.67	3.33	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00	18.15	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	33.09	0.00	0.00	0.00	18.53	3.97	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	0.00	0.00	1.11	3.33	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	34.01	0.63	0.00	0.00	13.86	5.04	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	0.00	0.00	0.00	18.56	7.73	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	29.27	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	34.24	0.00	0.65	0.65	12.27	2.58	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	0.00	0.00	0.00	20.93	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	28.52	0.00	0.00	0.81	16.30	2.44	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.91	0.00	0.00	0.00	10.50	1.68	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	71.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	0.00	0.00	0.80	13.66	4.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	0.00	0.00	0.00	18.47	1.85	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.60	0.00	0.00	0.47	5.66	1.89	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	28.12	0.00	0.00	0.00	11.79	4.53	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	36.59	0.00	0.00	1.08	7.53	4.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	0.00	0.00	0.00	7.62	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	43.36	0.00	0.00	0.00	14.67	1.28	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	1.82	0.00	0.00	7.29	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.27	0.00	0.00	0.00	19.99	2.86	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	0.00	3.32	0.00	16.59	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	31.48	0.00	0.93	0.00	9.88	3.40	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	0.00	0.00	0.00	28.10	1.76	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	0.00	0.00	0.00	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	0.00	0.00	0.00	29.21	2.09	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	0.00	0.00	0.00	37.62	13.28	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	0.00	0.00	0.00	68.08	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	0.00	0.00	0.00	55.80	8.72	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	2.25	0.00	0.00	60.74	15.75	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	0.00	0.00	94.08	20.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	0.00	0.00	0.00	58.67	24.54	1.07	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	0.00	0.00	0.00	67.89	18.01	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	0.00	0.00	0.00	8.55	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	0.00	0.00	0.00	41.42	9.20	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	0.00	0.00	54.46	15.13	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	0.00	0.00	62.09	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	26.43	0.00	0.00	0.00	35.95	7.40	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	26.19	0.08	0.08	0.16	25.95	6.61	2.94	1.31
Keratinocyte - epidermal, donor2	11349-117G8	19.91	0.00	0.00	0.00	15.81	5.27	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	39.00	0.00	0.00	0.09	31.24	5.96	0.76	0.09
Keratinocyte - oral, donor1	11251-116E9	61.07	0.45	0.23	0.23	25.65	9.54	4.20	1.48
Keratocytes, donor1	11527-119I6	23.38	0.00	0.00	0.00	9.97	2.75	1.38	0.34
Keratocytes, donor2	11607-120I5	12.89	0.00	0.00	0.00	10.55	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	41.69	0.00	0.00	0.20	9.09	3.95	0.40	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	85.72	0.00	4.40	0.00	123.08	35.17	10.99	10.99
Lens Epithelial Cells, donor1	11529-119I8	26.97	0.00	0.00	0.00	55.02	43.15	9.71	6.47
Lens Epithelial Cells, donor2	11609-120I7	49.25	0.23	0.12	0.00	44.98	18.91	18.34	4.96
Lens Epithelial Cells, donor3	11690-122I7	62.26	0.50	0.50	0.30	26.44	8.17	10.39	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	71.62	0.24	0.47	0.12	93.32	23.60	7.11	1.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.61	0.56	0.84	0.00	49.68	16.47	3.91	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	68.79	1.26	0.31	0.79	68.63	25.66	4.25	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.25	0.00	0.00	0.54	65.60	19.36	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	39.40	0.32	0.00	0.32	33.09	14.18	1.26	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.37	0.54	0.22	0.43	51.21	20.38	1.51	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	49.66	0.41	0.00	0.41	48.84	18.06	0.82	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	26.04	0.51	0.00	0.00	35.39	14.16	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	40.96	0.00	0.28	0.00	49.97	19.28	1.83	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	40.34	0.40	0.79	0.40	70.01	22.15	3.16	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	41.69	0.39	0.19	0.39	55.84	19.97	3.30	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.70	0.00	0.56	0.56	20.00	9.63	1.11	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	43.55	0.35	0.00	0.00	51.92	13.94	2.44	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	40.07	0.24	0.48	0.00	44.37	16.46	4.05	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	43.26	0.41	0.41	0.41	35.71	14.56	1.37	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.65	0.00	0.62	0.62	54.51	16.63	1.85	2.46
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.43	0.31	0.31	0.00	28.68	12.47	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	40.99	0.37	0.73	0.00	44.47	13.36	2.20	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.10	0.33	0.00	0.00	56.28	21.06	2.30	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.07	0.00	0.29	0.59	44.81	9.66	0.59	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.12	0.00	0.25	0.50	34.35	12.45	2.24	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	35.89	0.48	0.00	0.48	67.89	24.25	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.36	0.27	0.54	0.27	62.48	25.85	2.15	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	54.34	0.76	0.15	0.15	63.88	24.07	3.18	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	34.73	0.52	0.00	0.00	59.10	23.85	2.07	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	42.72	0.00	0.00	0.00	71.82	24.92	2.51	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	44.36	0.60	0.45	0.15	43.91	19.10	2.71	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	43.34	0.69	0.00	0.69	72.23	22.01	3.44	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.81	0.00	0.19	0.38	56.44	19.94	3.39	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	36.90	0.42	0.21	0.32	34.04	14.31	2.65	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.03	0.48	0.00	0.48	58.63	20.84	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.41	0.66	0.00	0.33	44.99	14.22	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	36.05	0.50	0.25	0.25	49.31	14.12	2.11	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.83	0.74	0.00	0.37	87.37	31.10	4.44	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.80	0.25	0.74	0.25	58.31	24.71	5.68	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.27	0.41	0.55	0.27	44.00	17.32	2.06	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	44.71	0.32	0.96	0.00	71.08	23.16	3.54	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.56	0.00	0.30	0.00	66.34	27.39	2.43	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	51.65	0.70	0.14	0.42	66.20	17.22	2.66	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	51.20	0.00	0.36	0.00	60.80	20.98	3.20	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	0.00	0.00	0.97	34.90	10.18	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.34	0.16	0.31	0.62	26.61	7.94	2.02	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	49.78	0.36	0.72	0.72	54.07	15.76	4.66	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.71	0.65	0.33	0.33	41.49	14.05	0.98	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.95	0.47	0.00	0.24	27.07	9.42	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	66.58	0.25	0.62	0.74	58.29	15.84	5.69	1.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	23.31	0.51	0.51	0.00	30.22	9.99	0.26	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	38.49	0.60	0.30	0.30	51.32	9.85	3.28	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	165.42	2.27	0.00	0.00	344.43	140.49	149.56	101.97
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	170.30	1.53	0.77	0.00	316.83	144.22	88.99	73.64
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	152.90	0.00	0.00	0.00	267.94	74.96	92.78	54.18
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	153.17	0.42	0.00	0.85	1179.26	353.74	191.25	149.79
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	136.44	0.00	0.70	0.00	680.11	267.26	141.37	104.80
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	123.28	1.87	0.00	0.93	567.85	138.23	134.49	82.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	136.03	1.03	0.52	1.03	975.40	254.54	147.37	133.97
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	128.46	0.00	0.00	0.00	810.02	296.18	141.55	113.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	208.32	0.23	0.45	0.23	606.65	235.47	192.49	125.08
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	149.78	0.29	0.00	0.87	590.38	209.11	85.21	86.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	164.31	0.00	0.45	1.80	513.20	159.81	95.89	91.39
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	238.18	0.54	0.68	0.68	683.12	253.90	198.62	147.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	144.30	2.05	0.51	0.51	938.72	291.17	142.25	125.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	161.61	0.00	0.00	0.35	497.17	150.67	87.51	75.86
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	140.59	0.67	0.00	1.33	380.46	75.96	65.96	65.96
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	154.85	0.00	0.00	0.00	1042.71	364.21	193.06	182.36
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	189.70	0.53	0.00	0.53	488.79	143.01	112.06	91.78
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	179.12	0.19	0.57	0.76	530.56	216.34	101.27	99.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	169.34	0.61	0.00	1.84	889.67	273.65	176.09	162.59
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	198.96	0.00	0.00	0.82	781.99	240.55	172.87	146.78
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	171.80	0.42	0.21	0.42	411.07	176.80	77.47	71.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	172.64	0.84	0.28	0.56	614.05	196.74	102.01	101.17
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	190.61	0.00	0.00	1.03	530.63	189.58	104.06	99.94
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	179.12	2.32	0.00	0.29	537.35	209.31	105.38	104.22
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	155.74	1.20	0.00	0.60	421.19	161.42	66.06	81.31
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	161.00	0.00	1.11	0.00	335.27	132.23	80.78	63.07
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	200.07	0.00	0.35	0.35	907.76	305.41	178.51	155.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	175.91	1.11	0.00	0.00	795.83	266.63	147.14	139.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	142.76	0.00	0.00	1.15	775.96	184.20	166.93	133.55
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	196.10	0.00	0.38	0.77	708.02	272.08	137.38	128.94
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	169.84	1.13	0.00	0.57	1049.04	348.74	195.88	198.71
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	132.10	0.00	0.82	0.82	614.53	166.56	177.22	141.12
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	161.77	0.45	0.00	0.45	755.10	255.77	137.82	161.32
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	149.37	1.44	0.00	0.72	644.89	212.57	127.11	127.83
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	187.47	1.49	0.75	0.75	528.06	177.02	168.80	134.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	172.42	0.37	0.00	0.00	747.27	205.12	152.72	134.89
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	160.67	0.00	0.86	0.86	494.07	185.65	107.69	96.06
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	172.97	0.86	1.71	0.86	651.64	174.68	194.38	134.44
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	181.58	0.67	0.67	0.00	630.04	234.56	130.27	116.61
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	161.08	0.60	0.60	1.81	649.16	232.27	140.57	131.52
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	173.48	0.00	0.71	0.00	498.41	174.19	198.37	125.85
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	180.45	0.34	0.34	0.00	654.09	267.41	145.39	158.80
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	171.76	0.00	0.00	0.54	726.22	236.17	164.78	121.30
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	173.73	0.00	0.00	0.00	649.79	198.64	206.05	141.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	190.76	0.00	0.74	0.74	956.76	314.11	178.17	191.87
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	205.84	1.16	1.16	0.00	608.21	124.43	241.89	153.51
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	129.04	3.17	0.00	0.00	506.66	160.78	155.49	112.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	157.66	0.40	0.00	1.20	734.28	268.50	154.46	126.85
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	148.28	0.73	1.45	0.00	1133.20	353.99	214.43	171.54
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	203.13	0.77	0.00	1.53	1398.13	426.95	340.33	244.52
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	184.49	0.99	0.00	0.00	1462.07	462.20	259.96	196.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	154.31	0.00	0.94	0.94	1476.32	396.13	253.11	192.89
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	174.98	0.00	0.00	0.50	1224.37	389.18	264.99	205.15
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	195.57	1.35	0.45	0.90	1350.97	434.40	227.11	215.40
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	142.85	1.72	0.00	0.00	2316.61	449.21	304.64	242.68
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	196.40	0.00	0.00	0.00	1820.12	615.46	401.70	271.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	178.70	0.78	0.78	0.39	1516.40	541.96	258.47	220.93
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	159.66	0.00	0.00	0.66	1984.48	643.24	274.45	226.29
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	206.53	2.08	0.00	0.52	1709.34	579.12	299.42	206.01
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	191.22	0.00	0.44	0.44	2216.27	623.53	299.30	282.67
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	162.70	0.56	0.00	0.00	1753.90	540.65	229.23	191.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	196.53	0.00	0.44	0.00	1730.35	749.47	301.64	211.10
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	200.96	0.00	1.54	0.00	1812.48	602.10	275.01	250.71
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	170.64	0.51	0.51	0.51	1716.04	472.43	210.64	169.12
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	206.19	0.48	0.48	1.44	1651.89	513.78	280.68	204.74
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	199.57	0.00	1.99	0.80	1475.69	473.08	188.83	171.34
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	177.43	0.00	0.00	0.61	1990.57	401.03	230.29	159.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	148.02	0.00	0.00	0.69	1835.78	65.02	200.59	189.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	194.18	0.38	0.00	0.38	1610.40	507.67	224.57	186.20
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	194.17	0.00	0.00	0.00	2231.44	522.10	276.28	223.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	184.42	0.60	0.00	0.00	1386.47	62.88	177.77	143.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	207.57	0.63	1.58	0.95	1247.32	465.53	191.41	169.86
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	176.99	1.07	0.53	0.53	1746.40	428.07	234.03	167.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	186.77	0.57	0.00	1.72	2173.40	83.90	262.05	189.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	165.58	0.51	0.00	0.51	1843.53	592.40	285.40	201.58
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	188.16	0.00	0.00	0.00	1306.48	360.75	186.74	143.59
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	191.24	0.57	0.00	0.00	1682.60	84.56	213.37	187.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	193.45	0.42	0.42	0.42	1265.96	379.83	193.04	175.56
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	197.33	0.78	0.00	0.78	1300.63	360.98	184.01	163.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	209.61	1.25	0.84	0.84	1036.35	61.80	139.46	109.81
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	183.07	1.39	0.93	1.39	962.26	362.42	136.14	129.63
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	183.99	0.00	0.67	0.67	857.05	263.60	139.83	96.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	197.82	1.07	1.07	1.07	881.63	41.70	135.80	97.84
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	215.79	0.00	1.62	1.21	1048.22	267.11	186.69	127.69
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	175.29	1.84	0.92	0.92	672.72	227.60	139.50	84.43
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	212.50	0.00	0.00	0.00	1118.50	29.34	148.48	110.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	200.59	0.00	0.00	1.14	978.47	277.53	194.33	148.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	191.72	0.77	0.00	0.77	768.43	206.30	149.55	117.34
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	202.46	0.55	1.09	1.64	976.71	33.92	128.59	119.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	214.26	0.00	0.00	0.45	835.21	215.15	171.50	143.43
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	351.46	0.00	0.78	1.30	662.89	242.54	240.72	133.10
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	223.47	0.00	0.66	0.66	908.46	37.13	180.37	114.05
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	178.76	4.16	0.00	0.00	1743.95	230.73	174.60	176.68
Macrophage - monocyte derived, donor1	11232-116C8	80.68	0.46	0.68	0.68	90.03	35.33	15.73	4.33
Macrophage - monocyte derived, donor2	11313-117C8	59.64	0.00	0.00	0.18	65.88	24.22	11.01	3.67
Macrophage - monocyte derived, donor3	11389-118C3	53.61	0.39	0.13	0.26	67.64	22.02	7.08	2.23
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	0.00	1.06	0.53	30.80	10.62	5.84	1.59
Mallassez-derived cells, donor2	11929-125I3	76.22	0.48	0.32	0.32	186.18	16.32	19.49	4.75
Mallassez-derived cells, donor3	11930-125I4	78.39	0.00	0.28	0.14	96.74	10.42	11.67	2.78
Mammary Epithelial Cell, donor1	11273-116H4	51.22	0.20	0.10	0.10	19.13	6.38	0.70	0.10
Mammary Epithelial Cell, donor2	11350-117G9	45.75	0.00	0.29	0.29	37.93	6.95	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	16.46	0.00	0.00	0.00	8.23	1.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	235.24	4.07	5.42	1.36	473.88	125.42	8.14	2.03
Mast cell, donor1	11563-120D6	94.73	2.27	1.84	1.08	32.98	8.76	1.41	0.22
Mast cell, donor2	11565-120D8	176.22	3.27	8.62	2.67	266.57	71.62	42.50	21.40
Mast cell, donor3	11566-120D9	173.57	6.08	6.08	2.93	553.36	163.22	43.90	29.72
Mast cell, donor4	11567-120E1	160.27	8.16	7.09	3.01	137.93	48.58	26.06	9.57
Mast cell, expanded and stimulated, donor5	11940-126A5	100.69	5.21	2.99	1.00	268.80	31.72	11.98	5.66
Mast cell, expanded and stimulated, donor8	11942-126A7	79.96	2.92	0.58	0.58	91.05	4.67	5.25	1.75
Mast cell, expanded, donor5	11939-126A4	92.92	3.21	3.21	1.26	67.69	7.34	3.10	0.23
Mast cell, expanded, donor8	11941-126A6	62.60	1.67	0.84	0.67	16.40	3.68	1.17	0.17
Melanocyte - dark, donor1	11502-119F8	68.36	1.29	1.29	0.99	15.82	3.08	1.29	0.30
Melanocyte - dark, donor2	11582-120F7	29.42	0.00	0.35	0.00	85.14	30.11	7.27	3.81
Melanocyte - dark, donor3	11663-122F7	114.89	0.29	0.22	0.65	8.84	2.83	0.87	0.36
Melanocyte - light, donor1	11274-116H5	40.20	0.00	0.00	0.24	5.41	3.06	1.41	0.00
Melanocyte - light, donor2	11351-117H1	36.85	0.68	0.00	0.00	4.78	0.68	1.36	0.00
Melanocyte - light, donor3	11423-118G1	32.95	0.00	0.00	0.87	5.20	2.60	3.47	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	64.97	0.10	0.00	0.21	12.39	3.44	1.46	1.35
Melanocyte, donor2 (MC+2)	12739-135I3	50.02	0.00	0.00	0.27	5.92	1.61	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	81.43	0.00	0.00	0.80	13.66	4.02	1.07	1.34
Meningeal Cells, donor1	11493-119E8	49.25	0.74	0.00	0.12	38.58	2.61	3.10	0.87
Meningeal Cells, donor2	11573-120E7	55.46	0.44	0.44	0.00	31.69	2.20	1.32	1.76
Meningeal Cells, donor3	11654-122E7	64.96	0.24	0.08	0.00	45.89	10.84	1.96	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	62.45	0.29	0.29	0.57	85.55	31.65	6.56	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	54.74	0.00	0.10	0.10	108.88	39.05	13.18	4.33
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	0.00	0.00	5.26	2.63	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	1.31	0.00	0.00	7.85	5.23	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	0.72	0.00	0.00	22.96	9.33	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	60.35	0.21	0.00	0.00	69.88	22.02	26.05	10.38
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.26	0.00	0.00	0.00	50.77	12.06	10.56	5.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.45	0.22	0.22	0.00	27.25	6.81	5.49	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	0.00	0.00	0.00	31.42	8.04	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.57	0.20	0.00	0.00	15.14	7.16	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	61.77	0.42	0.42	0.28	65.93	4.43	13.16	4.43
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.75	0.00	0.00	0.00	10.04	2.97	1.49	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.87	0.39	0.26	0.00	46.84	19.87	10.39	5.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.06	0.00	0.00	0.00	8.01	1.78	1.78	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	0.00	0.00	0.00	22.41	3.84	2.56	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	81.88	0.00	0.00	0.00	27.65	8.51	2.48	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	61.61	0.00	0.00	0.00	28.77	12.20	5.94	2.81
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	0.73	0.73	0.00	49.35	15.24	2.90	1.45
Mesothelial Cells, donor1	11247-116E5	70.01	0.00	0.00	0.53	60.73	22.27	12.73	6.36
Mesothelial Cells, donor2	12156-128G5	59.06	0.50	0.50	0.00	51.55	13.51	9.51	6.01
Mesothelial Cells, donor3	11402-118D7	41.55	0.22	0.07	0.00	49.93	16.77	6.50	3.18
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	0.00	2.70	1.35	35.11	4.05	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	62.06	0.25	0.49	0.49	65.26	6.40	6.16	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	50.06	0.29	0.29	0.00	16.49	4.71	1.77	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00	0.00	0.00	10.37	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.42	0.31	0.00	0.93	100.73	18.29	9.92	2.79
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.45	0.00	0.00	0.21	26.76	10.58	2.07	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00	0.00	0.00	9.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	56.56	0.50	0.00	0.50	106.61	20.77	14.26	4.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.62	0.00	0.00	0.00	19.55	3.72	1.86	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	48.16	0.20	0.00	0.41	94.90	22.35	10.97	3.25
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.99	0.79	0.00	0.40	24.15	5.94	1.19	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	0.88	0.88	0.00	141.59	18.58	13.27	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.13	0.38	0.76	0.00	26.60	10.26	1.90	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	1.32	0.00	0.00	5.26	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.81	0.85	0.21	0.64	79.80	18.04	10.40	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	0.00	0.00	0.00	3.68	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	0.00	0.30	0.89	29.81	8.94	2.68	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	0.00	0.00	0.00	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.40	0.25	0.25	0.25	42.65	16.06	3.26	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.27	0.00	0.00	0.00	12.83	7.13	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.91	1.11	0.00	1.11	13.27	3.87	1.66	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	40.75	0.23	0.00	0.23	67.00	21.18	3.68	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	42.91	0.21	0.21	0.00	16.41	5.47	2.10	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	33.63	0.20	0.41	0.00	19.57	15.49	1.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.97	0.64	0.00	0.21	59.43	22.74	4.51	2.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.68	0.67	0.00	0.22	13.78	7.11	1.11	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.95	0.22	0.44	0.00	29.79	14.46	2.41	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	0.00	0.00	1.01	11.66	3.04	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	0.00	0.00	0.00	4.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	30.17	0.00	0.00	0.00	43.21	15.76	2.45	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	31.76	0.59	0.29	0.00	23.53	7.06	2.06	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	1.09	0.00	0.00	10.90	5.45	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	31.24	0.48	0.48	0.48	63.91	23.07	4.81	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.41	0.00	0.00	0.80	33.22	8.81	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	0.00	0.00	2.74	38.39	8.23	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.54	0.50	0.50	0.00	54.56	29.03	4.51	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	107.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	0.00	2.04	0.00	8.15	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.15	0.00	0.88	0.44	74.45	26.28	7.88	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	1.10	0.00	0.00	17.66	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	26.26	0.00	0.64	0.00	11.53	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	36.94	0.25	0.00	0.50	112.80	40.16	9.17	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	0.00	0.00	0.00	33.40	4.18	5.57	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	2.21	0.00	0.00	11.05	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	39.66	0.00	0.00	0.34	131.96	43.08	12.31	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.51	0.44	0.00	0.88	29.76	2.63	3.06	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	35.51	0.00	0.36	0.36	44.74	5.68	2.49	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	32.26	0.00	0.28	0.28	136.07	44.33	11.78	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.94	0.42	0.42	0.00	42.81	1.25	4.99	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	21.56	0.00	0.58	0.58	16.32	2.91	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	26.85	0.00	0.60	0.30	80.24	22.02	7.84	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.80	0.42	0.83	0.00	68.45	5.43	9.60	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	7.22	0.00	43.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	0.92	0.00	0.00	146.85	35.10	7.39	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.59	0.00	0.00	0.00	85.37	5.12	9.68	4.55
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.82	0.00	0.14	0.14	44.91	6.77	4.56	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	36.54	0.00	0.52	0.26	90.70	27.99	7.77	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	35.18	0.00	0.00	0.86	48.47	4.29	6.01	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	30.49	0.00	0.00	1.27	15.24	3.81	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.02	0.00	0.00	0.27	58.72	16.55	5.34	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	61.66	0.00	0.60	0.00	100.87	12.57	12.57	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.77	0.14	0.14	0.14	33.90	5.51	2.97	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	32.81	0.00	0.00	0.64	99.69	29.62	7.64	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.69	0.00	0.44	0.22	83.37	7.74	9.29	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.34	0.00	0.38	0.00	23.51	5.31	2.28	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.06	0.00	0.00	0.28	143.76	36.65	15.06	3.98
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.07	0.74	0.49	0.00	110.61	14.50	13.03	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	56.04	0.00	0.00	0.65	74.29	9.12	3.91	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	46.75	1.18	0.29	0.88	105.56	23.82	10.88	3.53
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	59.40	0.29	0.00	0.29	108.41	12.40	14.13	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	52.34	0.00	0.00	0.41	222.56	34.21	18.13	5.77
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	42.88	0.30	0.30	0.00	72.06	22.63	8.34	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00	67.80	30.14	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	0.00	0.00	1.78	87.33	30.30	5.35	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	50.93	0.33	0.00	0.99	118.94	30.23	5.26	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	43.13	0.00	0.00	1.05	88.36	28.40	4.21	6.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	51.60	0.79	0.40	0.20	74.92	15.42	18.78	8.11
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	56.81	0.00	0.00	1.86	70.78	18.63	8.38	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	50.70	0.38	0.75	0.38	36.43	9.39	3.38	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	41.02	0.53	0.27	0.80	36.76	11.72	5.33	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	69.67	0.68	0.45	0.45	53.50	9.84	19.34	4.98
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	42.73	0.00	0.74	0.74	54.52	14.00	5.16	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	38.11	0.00	0.37	0.37	81.35	21.62	6.60	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	0.00	0.00	1.56	129.11	52.89	14.00	9.33
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	65.74	0.00	0.00	0.53	31.53	9.62	3.74	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	0.00	30.91	0.00	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	36.36	0.00	0.00	0.00	59.59	8.08	6.06	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	0.84	0.42	0.00	30.78	13.49	2.95	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	49.03	1.36	0.00	0.00	153.90	21.79	13.62	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	91.55	0.00	0.64	0.00	90.92	6.36	3.18	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	92.32	1.62	0.00	0.00	233.23	17.01	5.67	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	0.00	0.00	0.00	155.57	45.31	3.02	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00	0.00	336.90	22.84	22.84	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	3.26	3.26	0.00	936.32	75.04	52.20	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	0.00	0.00	0.00	351.68	28.51	28.51	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	188.24	75.29	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	63.77	0.22	0.43	0.00	49.77	11.42	10.34	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.61	0.00	0.00	0.00	51.22	14.11	11.50	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	0.00	0.00	0.00	60.74	8.01	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.29	0.00	0.00	0.00	34.22	5.84	1.67	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	64.08	0.19	0.19	0.57	284.45	38.79	12.17	6.08
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	1.60	0.00	1.60	232.99	15.96	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	0.00	0.00	0.00	61.87	12.92	2.72	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	132.31	0.00	3.68	0.00	218.68	159.87	7.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	0.00	0.00	0.00	144.39	18.83	8.37	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.34	0.23	0.23	0.23	99.02	15.57	4.65	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.05	0.00	0.00	0.00	109.98	13.78	9.19	4.86
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.18	0.21	0.21	0.21	231.26	27.75	11.98	5.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	222.69	0.00	0.00	0.00	790.57	690.35	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.87	0.00	0.00	0.00	108.21	17.37	4.96	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	22.19	0.00	0.81	0.27	260.66	58.46	27.07	13.26
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.05	0.23	0.00	0.00	110.17	19.95	6.35	4.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.66	0.16	0.00	0.00	69.24	11.59	7.68	4.57
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	23.33	0.55	0.18	0.18	257.16	29.89	18.04	16.59
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	0.00	0.00	0.00	118.82	19.63	8.49	7.96
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	0.00	0.00	0.00	141.67	18.01	6.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	53.49	0.66	0.00	0.66	486.69	101.41	45.94	32.16
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.34	0.16	0.00	0.33	93.67	15.77	4.88	5.04
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.22	0.18	0.18	0.53	256.99	26.28	20.99	11.11
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	0.70	0.00	0.00	132.91	9.14	7.03	5.63
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.63	0.00	0.00	0.00	176.99	26.66	12.41	10.11
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.64	0.64	0.00	0.00	162.28	23.78	23.46	14.78
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	57.25	0.00	0.34	0.34	621.83	187.96	33.80	22.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	242.73	0.00	2.53	0.00	316.06	144.12	37.93	35.40
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.06	0.22	0.22	0.67	165.97	16.04	11.14	8.47
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	0.85	0.42	0.85	157.50	25.83	11.85	9.74
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.58	0.00	0.00	0.00	287.43	44.38	22.55	14.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.89	0.00	0.00	0.00	111.18	15.02	21.03	9.87
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	433.33	0.00	0.00	9.03	866.66	857.64	108.33	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.33	0.33	0.00	0.00	100.63	14.00	10.00	4.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.47	0.90	0.00	0.45	103.70	19.39	16.23	7.21
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.27	0.00	0.00	0.00	134.91	12.30	12.70	4.36
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	0.00	0.00	0.00	162.51	23.22	17.64	10.22
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	26.11	0.00	0.00	0.00	250.48	43.13	33.68	21.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.69	0.00	0.00	0.00	69.41	7.82	6.52	4.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	0.00	0.00	0.00	49.68	7.41	4.36	3.92
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	0.45	0.00	0.00	173.68	16.28	16.73	9.05
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	0.00	0.00	0.00	166.68	25.58	8.82	9.70
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	0.00	0.00	0.66	165.55	31.25	17.95	11.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.83	0.00	0.50	0.00	134.43	17.36	17.36	20.34
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	0.00	0.00	0.00	96.85	16.08	7.27	6.13
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	54.44	0.30	0.00	0.30	101.02	23.89	30.24	24.20
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.51	0.22	0.00	0.22	205.77	26.74	14.81	8.62
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	0.00	0.00	0.00	134.18	13.55	15.59	8.81
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	153.29	0.00	0.00	5.11	505.84	413.87	76.64	45.99
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	0.61	0.00	0.00	114.62	20.12	19.51	6.71
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.14	0.31	0.00	0.00	68.93	17.31	7.24	4.72
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.28	0.30	0.00	0.30	66.28	13.92	6.66	5.45
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	0.00	0.00	0.00	136.87	20.57	16.61	11.87
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	102.03	1.13	0.00	1.13	740.27	256.20	71.42	79.36
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	192.20	0.00	0.00	0.00	622.12	419.80	65.75	30.35
Myoblast, donor1	11241-116D8	57.64	0.12	0.12	0.50	47.95	12.80	2.98	0.99
Myoblast, donor2	11322-117D8	36.44	0.00	0.19	0.38	47.56	21.10	2.30	1.53
Myoblast, donor3	11398-118D3	53.31	0.34	0.34	0.17	40.70	12.78	6.89	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	57.50	4.38	1.61	1.31	87.12	25.98	5.11	2.92
Natural Killer Cells, donor1	11230-116C6	58.12	13.53	5.54	0.62	60.58	18.45	5.54	0.62
Natural Killer Cells, donor2	11311-117C6	41.61	9.95	3.32	0.90	90.47	39.81	3.62	0.30
Natural Killer Cells, donor3	11387-118C1	45.28	9.75	3.87	0.92	103.99	29.82	3.87	2.76
Neural stem cells, donor1	11275-116H6	60.97	0.36	0.36	0.00	38.11	13.43	8.35	3.27
Neural stem cells, donor2	11352-117H2	38.51	0.00	0.00	0.00	21.18	13.48	5.78	0.00
Neurons, donor1	11494-119E9	80.79	1.14	0.00	0.00	39.83	18.21	7.97	1.14
Neurons, donor2	11574-120E8	60.10	1.32	0.66	0.22	24.00	13.21	3.96	0.66
Neurons, donor3	11655-122E8	43.57	0.00	0.00	0.00	92.08	19.73	7.40	2.47
Neutrophils, donor1	11233-116C9	1121.03	116.93	221.79	94.66	3.71	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	791.39	69.57	150.74	84.07	0.00	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	1273.61	259.00	463.02	196.69	33.60	7.94	5.50	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	66.97	0.83	0.83	0.71	37.28	14.37	12.11	5.46
Nucleus Pulposus Cell, donor2	11409-118E5	21.82	0.00	0.00	0.00	60.24	13.68	4.23	5.86
Nucleus Pulposus Cell, donor3	11462-119B4	34.09	0.80	0.20	0.60	25.07	3.81	4.01	1.00
Olfactory epithelial cells, donor1	11933-125I7	19.82	0.00	0.14	0.00	127.05	32.35	13.35	12.80
Olfactory epithelial cells, donor2	11934-125I8	28.95	0.00	0.00	0.00	120.43	21.13	4.34	2.61
Olfactory epithelial cells, donor3	11935-125I9	22.47	0.11	0.00	0.23	124.51	19.07	6.47	5.56
Olfactory epithelial cells, donor4	11936-126A1	32.14	0.10	0.00	0.00	51.91	13.44	6.04	4.77
Oligodendrocyte - precursors, donor1	11496-119F2	73.42	0.00	0.60	0.60	48.15	18.05	13.24	9.63
Osteoblast - differentiated, donor1	11276-116H7	44.88	1.06	1.28	0.21	25.31	7.66	6.81	2.98
Osteoblast - differentiated, donor2	11353-117H3	25.15	0.00	0.00	0.00	3.43	2.29	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	25.45	0.00	0.00	0.00	10.55	4.97	2.48	0.00
Osteoblast, donor1	11277-116H8	61.76	0.20	0.20	0.39	61.37	20.52	6.84	3.91
Osteoblast, donor2	11354-117H4	68.12	0.00	0.00	0.70	62.51	12.64	2.81	0.70
Osteoblast, donor3	11426-118G4	49.59	0.18	0.00	0.00	27.37	9.42	4.80	2.67
Pancreatic stromal cells, donor1	11249-116E7	47.42	0.08	0.17	0.25	50.71	10.95	4.97	2.11
Pericytes, donor1	11491-119E6	9.24	0.00	0.00	0.11	9.46	0.56	2.45	1.00
Pericytes, donor2	11571-120E5	11.54	0.00	0.00	0.00	13.36	0.45	2.04	2.49
Pericytes, donor3	11652-122E5	22.58	0.00	0.00	0.00	26.65	13.63	2.24	1.83
Perineurial Cells, donor1	11499-119F5	56.17	0.00	0.45	0.34	71.99	21.36	10.85	2.71
Perineurial Cells, donor2	11579-120F4	63.86	0.37	0.28	0.18	76.65	16.10	13.99	5.34
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	120.48	14.02	5.74	1.91	18.49	6.69	1.59	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	85.70	7.84	4.65	1.47	30.12	14.69	1.96	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	64.32	6.21	3.11	1.16	37.79	8.93	4.14	1.68
Placental Epithelial Cells, donor1	11278-116H9	24.63	0.00	0.00	0.00	2.87	0.96	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	23.29	0.00	0.00	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.90	0.00	0.00	0.00	1.37	0.39	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	40.19	0.00	0.32	0.32	4.75	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	51.77	0.19	0.00	0.19	71.47	22.51	10.32	4.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	74.40	0.52	0.26	0.00	403.85	116.95	51.04	11.09
Preadipocyte - breast, donor2	11328-117E5	38.05	0.00	0.00	0.45	61.69	38.73	6.30	3.38
Preadipocyte - omental, donor1	11468-119C1	55.84	0.32	0.43	0.43	64.89	21.84	11.40	5.33
Preadipocyte - omental, donor2	11329-117E6	68.09	0.44	0.44	0.44	94.28	33.61	18.33	6.55
Preadipocyte - omental, donor3	11403-118D8	63.46	0.14	0.00	0.00	76.49	23.21	10.60	3.58
Preadipocyte - perirenal, donor1	11469-119C2	36.42	0.00	0.00	0.98	70.87	0.00	4.92	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	60.20	0.00	0.00	0.00	51.60	12.90	3.99	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	55.96	0.00	0.18	0.18	43.38	23.20	1.06	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	50.57	0.17	0.51	0.00	46.83	16.52	2.72	1.19
Preadipocyte - visceral, donor1	11280-116I2	58.12	0.28	0.00	0.28	62.97	20.40	2.89	1.02
Preadipocyte - visceral, donor2	11357-117H7	38.66	0.46	0.00	0.00	53.38	11.50	2.30	0.00
Preadipocyte - visceral, donor3	11429-118G7	37.20	0.21	0.31	0.31	39.50	3.24	0.42	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	131.39	0.30	0.60	0.60	67.13	19.31	18.55	6.94
Prostate Epithelial Cells, donor2	11331-117E8	34.40	0.00	0.00	0.14	34.94	19.50	2.84	1.49
Prostate Epithelial Cells, donor3	11404-118D9	30.01	0.31	0.12	0.12	36.44	9.43	0.73	0.49
Prostate Stromal Cells, donor1	11254-116F3	58.77	0.23	0.34	0.11	73.58	21.30	6.95	3.30
Prostate Stromal Cells, donor2	11332-117E9	40.16	0.00	0.36	0.18	55.94	29.40	1.61	2.15
Prostate Stromal Cells, donor3	11405-118E1	31.28	0.10	0.00	0.00	19.08	6.99	2.40	1.98
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	0.00	0.00	0.00	34.67	11.68	5.47	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	62.66	0.21	0.21	0.14	70.56	22.04	7.83	4.57
Renal Epithelial Cells, donor1	11517-119H5	11.16	0.00	0.00	0.00	46.16	15.72	13.70	2.54
Renal Epithelial Cells, donor2	11597-120H4	9.25	0.00	0.00	0.00	48.37	16.36	9.25	1.42
Renal Epithelial Cells, donor3	11678-122H4	74.21	0.32	0.21	0.21	85.22	32.08	14.61	8.15
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	0.68	0.00	0.00	14.30	0.68	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.31	0.00	0.00	0.40	37.87	2.43	1.21	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	47.07	0.44	0.22	0.22	40.63	8.44	4.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	0.00	0.00	0.00	24.62	2.66	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	21.13	0.00	0.00	0.22	31.69	7.26	11.22	4.62
Renal Mesangial Cells, donor2	11598-120H5	18.18	0.00	0.00	0.00	58.31	21.32	9.40	10.66
Renal Mesangial Cells, donor3	11679-122H5	7.21	0.00	0.00	0.00	11.65	7.77	3.05	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.31	0.00	0.00	0.00	57.98	13.15	8.05	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	17.29	0.00	0.00	0.00	45.96	11.39	3.37	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.16	0.39	0.19	0.00	32.98	20.83	3.47	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	51.86	0.26	0.26	0.26	20.74	8.82	3.37	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	26.15	0.28	0.28	0.00	39.23	15.35	18.48	7.96
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	0.00	0.00	0.00	14.41	8.23	0.00	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	34.88	1.00	0.00	0.25	48.93	10.29	5.02	3.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	73.37	2.81	2.00	0.94	46.64	24.05	9.89	4.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	82.19	0.00	0.89	0.00	5.36	1.79	3.57	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	122.18	0.00	0.00	1.10	20.36	4.40	3.30	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	89.33	0.00	0.00	0.00	5.22	0.00	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	99.21	0.65	0.39	0.52	39.66	0.78	3.77	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	67.92	0.50	0.20	0.30	16.09	6.36	1.99	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	113.77	0.33	0.00	0.67	23.31	9.59	2.79	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	128.14	0.25	0.25	0.50	51.85	6.33	5.09	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	75.40	0.12	0.12	0.12	26.22	10.02	1.40	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	92.45	0.69	0.46	0.46	28.66	11.33	2.54	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	74.75	0.27	0.14	0.55	29.85	1.23	2.19	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	72.61	0.15	0.15	0.45	22.09	5.60	2.42	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	94.79	0.54	0.54	0.72	18.64	6.63	4.66	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	78.04	0.72	0.14	0.29	33.43	2.73	2.44	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	64.71	0.32	0.21	0.32	19.32	7.51	2.15	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	72.13	0.66	0.00	0.44	15.71	5.09	1.99	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	69.40	0.19	0.38	0.19	20.84	0.96	2.68	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	68.85	0.28	0.09	0.65	8.11	2.79	0.93	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	126.46	0.75	0.19	0.56	16.91	5.83	2.63	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	79.23	1.06	0.27	0.53	20.57	0.53	1.59	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	72.32	0.49	0.19	0.29	7.20	3.41	0.78	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	91.28	0.38	0.38	0.19	10.88	7.64	2.10	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	77.85	0.43	0.21	0.32	26.48	0.96	1.92	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.11	1.40	0.28	0.00	10.37	4.20	1.68	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	80.83	0.34	0.34	0.17	9.91	3.93	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	83.69	0.73	0.00	0.18	20.79	0.55	1.64	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	60.34	0.12	0.00	0.25	6.74	3.07	0.86	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	90.67	0.40	0.13	0.27	9.00	3.36	0.94	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	79.96	0.47	0.47	0.24	37.98	1.18	3.07	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	70.44	0.00	0.40	0.20	9.33	3.57	0.99	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	86.76	0.70	0.00	0.23	23.15	7.72	1.64	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	85.02	0.62	0.00	0.21	26.75	1.24	2.28	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	73.44	0.44	0.22	0.22	19.69	3.32	1.33	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	82.09	0.21	0.42	0.21	11.07	3.55	2.09	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	88.83	0.27	0.13	0.67	30.69	1.75	2.56	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	70.67	0.00	0.17	0.51	10.90	4.77	0.68	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	79.43	0.19	0.19	0.19	17.35	5.98	0.58	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	82.36	0.86	0.00	0.17	51.75	1.89	2.75	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.03	0.82	0.14	0.27	10.15	4.12	0.69	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	90.62	0.33	0.82	0.00	37.59	11.66	2.46	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	70.05	0.34	0.00	0.34	49.25	2.22	5.45	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	82.26	0.30	0.30	0.59	33.88	12.58	2.96	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	66.37	0.27	0.27	0.00	22.66	6.66	1.07	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	74.25	0.14	0.28	0.41	23.51	1.80	2.63	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	75.95	0.48	0.24	0.48	7.62	6.67	0.24	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	80.62	0.40	0.20	0.60	9.67	4.84	1.61	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	66.58	0.57	0.09	0.19	9.61	0.38	1.51	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	67.43	0.35	0.00	0.00	12.23	6.29	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	64.98	1.21	0.30	0.30	4.23	2.72	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	76.12	0.86	0.00	0.37	20.81	0.73	2.81	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	160.40	0.87	0.29	0.87	40.46	16.16	8.44	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	92.48	1.22	0.61	1.22	16.43	7.91	2.43	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	84.09	0.30	0.30	0.00	25.02	1.21	1.81	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	107.21	0.45	0.23	0.45	11.54	8.60	1.81	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	97.05	0.60	0.00	0.60	14.08	6.29	2.10	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	132.72	0.35	0.12	0.35	47.23	1.89	4.84	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	110.99	0.43	0.00	0.64	14.51	5.34	2.13	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	90.75	0.60	0.00	0.00	13.22	12.62	1.80	2.40
Schwann Cells, donor1	11498-119F4	10.53	0.00	0.00	0.00	33.66	2.82	2.63	0.56
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00	17.01	13.61	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.93	0.00	0.44	0.00	69.23	17.96	5.26	3.94
Sebocyte, donor1	11220-116B5	67.38	0.00	0.55	0.00	69.57	26.29	4.93	1.10
Sebocyte, donor2	11301-117B5	22.06	0.00	0.00	0.00	33.09	21.60	3.22	1.38
Sebocyte, donor3	11378-118B1	23.50	0.00	0.00	0.00	40.81	19.17	3.92	4.95
Sertoli Cells, donor1	11255-116F4	67.92	0.00	1.66	1.66	106.02	36.45	13.25	8.28
Sertoli Cells, donor2	11333-117F1	25.42	0.00	0.00	0.00	64.96	39.54	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.38	0.35	0.35	0.18	35.10	12.67	5.37	2.29
Skeletal Muscle Cells, donor2	11358-117H8	10.84	0.00	0.00	0.00	7.23	7.95	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	26.75	0.84	0.00	0.84	44.31	3.34	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	38.80	0.31	0.16	0.31	69.59	6.76	5.50	4.56
Skeletal Muscle Cells, donor5	11455-119A6	34.93	0.30	0.15	0.15	63.47	6.09	5.05	3.72
Skeletal Muscle Cells, donor6	11459-119B1	44.79	0.00	0.00	0.46	113.58	8.77	4.00	2.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	59.10	0.50	0.50	0.50	151.71	56.58	31.00	20.41
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.25	0.86	0.14	0.14	47.09	26.25	3.28	4.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	47.42	0.40	0.30	0.10	52.98	17.36	6.15	3.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.07	0.59	0.00	0.42	32.94	12.13	6.49	2.78
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	0.00	0.00	0.00	14.48	4.34	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	33.02	0.55	0.14	0.00	40.04	3.58	3.85	3.16
Skin - palm, donor1	10286-104F7	91.33	2.69	0.00	2.69	16.12	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.75	0.00	0.00	0.00	12.25	1.44	0.72	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	122.68	0.82	0.00	0.82	1288.18	30.26	77.70	28.63
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.93	0.13	0.00	0.00	20.25	1.69	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	53.24	0.00	0.42	0.14	72.70	17.10	3.48	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	31.51	0.28	0.14	0.00	28.27	11.96	0.56	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.05	0.21	0.42	0.42	904.78	200.24	88.17	22.41
Small Airway Epithelial Cells, donor3	11406-118E2	31.33	0.07	0.07	0.22	50.59	11.24	1.57	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.02	0.00	0.00	0.00	4.32	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	95.60	0.00	0.22	0.00	294.14	16.67	9.34	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.32	0.59	0.00	0.59	65.25	19.99	6.47	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.22	0.22	0.00	0.22	21.22	6.63	5.75	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	44.10	0.00	0.00	0.00	19.69	3.54	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	60.26	0.00	0.00	0.00	117.43	23.18	11.59	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	37.03	0.00	0.00	0.00	71.05	26.02	20.02	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	78.78	0.00	0.13	0.40	29.81	9.71	2.93	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.11	0.22	0.22	0.00	53.86	29.92	3.10	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	85.52	0.00	0.38	0.38	104.22	7.04	6.53	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	55.02	0.00	0.00	0.00	26.37	14.65	5.86	2.28
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	55.23	0.30	0.30	0.00	93.62	33.37	24.51	9.45
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	39.86	0.14	0.00	0.14	34.45	15.23	7.40	3.70
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.66	0.16	0.00	0.00	13.18	3.42	1.79	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	36.23	0.30	0.61	0.30	21.61	9.44	1.83	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	38.39	0.25	0.25	0.76	41.17	12.88	3.54	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	0.00	0.00	0.00	18.36	6.12	18.36	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	44.35	0.00	0.00	0.00	38.62	3.34	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.35	0.15	0.29	0.00	28.02	11.65	7.96	3.54
Smooth Muscle Cells - Colonic, donor2	11320-117D6	33.79	0.00	0.22	0.22	35.51	20.45	4.74	2.80
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.40	0.21	0.10	0.31	41.88	12.49	5.25	3.46
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	50.43	0.00	0.15	0.31	25.83	5.41	1.86	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	33.41	0.00	0.00	0.00	15.09	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.77	0.30	0.00	0.30	32.58	3.59	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	0.00	0.00	0.00	15.02	5.80	2.05	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	52.30	0.24	0.00	0.00	68.08	26.94	10.52	6.60
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	45.39	0.10	0.00	0.30	40.06	15.40	3.72	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	60.76	0.23	0.00	0.23	41.64	20.25	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	47.10	0.00	0.00	0.00	35.02	4.23	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.06	0.00	0.00	0.26	41.86	9.80	5.30	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	62.58	0.40	0.27	0.00	44.21	1.33	5.46	2.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.94	0.13	0.00	0.13	54.35	26.30	5.38	3.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.30	0.00	0.25	0.25	31.20	8.62	9.64	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	53.98	0.15	0.60	0.00	32.11	8.74	1.66	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	0.00	0.00	0.00	20.25	10.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	0.00	1.29	0.00	24.55	1.29	6.46	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	45.58	1.40	0.00	0.00	71.16	13.95	9.77	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.93	0.00	0.00	0.00	19.19	8.08	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	52.65	0.00	0.63	0.31	26.95	1.88	1.25	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.27	0.29	0.00	0.00	13.27	4.42	1.77	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	49.07	0.17	0.08	0.17	26.82	6.75	1.75	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	0.00	0.00	0.47	35.97	12.61	2.80	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	76.42	0.00	0.29	0.72	36.84	11.08	6.76	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	49.72	0.00	0.51	0.51	49.46	15.04	4.08	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.91	0.19	0.00	0.19	59.61	5.64	2.63	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	64.56	0.42	0.14	0.28	61.91	12.86	6.71	2.52
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	56.89	0.00	0.34	0.17	7.62	3.69	2.26	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	0.00	0.00	0.00	19.05	2.86	1.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	85.88	0.24	0.49	0.24	28.87	8.81	3.18	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	59.44	0.00	0.00	0.22	79.76	5.30	8.40	3.31
Smooth Muscle Cells - Uterine, donor3	11466-119B8	46.52	0.00	0.00	0.00	59.39	14.34	1.76	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	33.43	0.00	0.19	0.00	95.24	13.80	12.83	5.25
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	27.24	0.00	0.00	0.26	62.68	4.76	3.17	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.03	0.00	0.00	0.00	147.29	12.27	12.27	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	52.82	0.00	0.36	0.00	58.57	4.67	6.47	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.36	0.00	0.00	0.57	30.66	2.56	2.27	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	33.48	0.00	0.00	0.00	113.43	4.33	2.76	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	30.98	0.00	0.25	0.00	156.69	12.70	14.98	8.38
Smooth muscle cells - airway, control, donor2	11967-126D5	29.95	0.40	0.00	0.40	116.60	18.77	24.36	8.39
Smooth muscle cells - airway, control, donor3	11968-126D6	25.08	0.00	0.00	0.00	165.11	18.81	21.32	9.20
Smooth muscle cells - airway, control, donor4	11969-126D7	27.96	0.00	0.00	0.00	150.80	22.00	15.13	7.79
Synoviocyte, donor1	11291-117A4	41.74	0.17	0.00	0.17	100.99	37.54	11.11	4.71
Synoviocyte, donor2	11368-117I9	30.51	0.50	0.17	0.84	46.10	14.08	3.18	1.01
Synoviocyte, donor3	11440-118H9	27.03	2.01	0.22	0.22	47.81	5.59	5.14	2.68
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	0.00	0.36	0.00	11.79	2.86	2.14	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	0.00	0.00	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.18	0.00	0.00	0.00	9.96	3.01	0.93	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	43.23	0.22	0.14	0.29	39.35	11.61	1.94	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	24.35	0.00	0.00	0.00	32.47	7.34	2.71	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	21.76	0.00	0.00	0.00	38.37	3.44	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	70.86	2.21	1.72	0.49	42.94	22.14	8.37	6.15
Urethra, donor2	10319-105A4	53.95	1.80	0.00	0.00	109.70	14.39	16.19	19.78
Urothelial Cells, donor1	11520-119H8	16.21	0.00	0.00	0.27	37.99	11.69	3.19	1.86
Urothelial Cells, donor2	11600-120H7	14.82	0.00	0.00	0.00	45.26	16.02	3.20	1.20
Urothelial Cells, donor3	11681-122H7	6.42	0.00	0.00	0.00	16.73	11.23	2.06	1.15
Urothelial cells, donor0	11216-116B1	67.76	0.22	0.00	0.00	51.27	23.18	7.36	3.79
Whole blood (ribopure), donor090309, donation1	12179-129A1	541.88	73.85	83.64	56.95	41.82	4.45	6.23	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	561.84	75.77	92.92	45.75	37.17	11.44	2.86	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	253.96	39.70	61.61	35.60	22.59	12.32	3.42	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	336.42	37.19	54.41	22.73	25.48	7.58	3.10	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	340.48	39.51	48.81	19.17	44.74	5.23	4.07	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	557.06	81.22	82.26	58.31	41.65	1.04	5.21	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	498.36	64.25	64.25	47.73	50.48	1.84	3.67	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	236.44	36.52	40.17	19.17	23.74	16.43	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	77.84	1.48	0.99	0.74	64.89	21.46	3.33	0.74
Wilms' tumor cell line:HFWT	10597-108E3	68.64	0.88	2.64	0.88	33.44	9.68	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	36.31	0.00	0.56	0.00	11.17	5.59	1.12	0.28
achilles tendon, donor2	10292-104G4	66.13	4.13	2.07	0.00	175.65	53.73	6.20	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.24	1.02	0.25	1.02	18.36	6.12	3.06	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	54.10	2.09	1.16	3.02	0.00	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	46.77	1.31	0.83	1.31	1.07	0.59	0.24	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	62.04	1.36	2.45	1.36	8.98	1.90	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	41.32	0.56	0.00	0.00	32.89	8.15	0.56	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	90.30	2.54	1.06	1.69	39.76	8.25	1.90	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.05	0.00	0.27	0.00	11.43	1.63	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	62.13	0.44	0.44	0.00	16.74	1.32	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	55.13	1.23	0.00	0.41	11.84	3.27	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	41.16	0.78	0.39	0.78	15.14	6.99	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.25	0.37	0.00	0.74	1.47	0.55	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	85.81	0.00	0.00	0.00	54.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.34	0.70	0.46	0.46	0.93	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.89	0.52	0.00	0.00	42.46	10.10	1.55	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.47	0.00	0.29	0.29	20.75	8.18	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	32.53	0.00	0.00	0.46	48.34	7.90	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.01	0.00	0.41	0.82	13.16	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.93	0.31	0.31	0.31	3.07	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	46.51	0.43	0.00	0.00	37.98	5.12	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.01	0.30	0.61	1.21	22.44	6.07	0.91	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	47.90	0.24	0.24	0.24	17.33	1.93	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	27.62	0.67	0.22	0.67	4.23	2.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.69	0.33	0.33	0.33	15.68	2.00	1.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	42.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	47.08	0.38	0.38	0.00	3.77	1.13	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	35.33	0.00	0.44	0.44	0.00	0.00	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	0.00	0.00	1.87	58.11	28.12	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	77.24	0.24	0.24	0.47	81.95	13.42	23.55	4.95
adipose tissue, adult, pool1	10010-101C1	53.98	3.41	1.24	1.09	32.89	8.07	5.12	3.57
adipose, donor1	10184-103D4	85.03	1.17	0.00	0.00	14.66	7.62	2.93	2.93
adipose, donor2	10185-103D5	22.71	0.00	0.00	0.00	17.03	6.49	2.03	0.41
adipose, donor3	10186-103D6	33.76	0.54	0.27	0.00	47.38	14.43	10.89	2.45
adipose, donor4	10187-103D7	58.07	0.00	1.73	0.00	68.47	22.54	26.87	13.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	137.62	0.47	1.26	1.89	39.30	11.36	3.31	1.42
adrenal gland, adult, pool1	10081-102A9	61.84	0.00	0.00	0.00	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	57.50	1.20	0.80	0.93	223.59	96.19	38.95	21.21
alveolar cell carcinoma cell line:SW 1573	10708-109H6	163.29	1.79	0.36	0.71	82.89	33.23	2.50	1.79
amniotic membrane cells, donor1	12235-129G3	51.70	0.46	0.23	0.46	17.62	3.48	4.64	0.70
amniotic membrane cells, donor2	12236-129G4	50.72	0.34	0.00	0.00	1.01	0.34	3.04	1.35
amniotic membrane cells, donor3	12237-129G5	44.78	0.29	0.00	0.00	14.73	3.24	3.24	2.95
amygdala - adult, donor10196	10167-103B5	58.10	0.00	1.19	0.00	30.83	10.67	3.56	4.74
amygdala, adult, donor10252	10151-102I7	65.09	1.22	0.41	1.01	4.26	2.84	1.42	0.00
amygdala, newborn, donor10223	10360-105E9	44.86	0.32	0.65	1.61	37.12	8.39	4.20	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	56.41	0.13	0.25	0.25	92.44	49.02	17.19	6.37
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.45	0.00	0.00	0.22	97.07	43.24	9.27	3.09
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	57.45	0.00	0.00	0.00	6.35	5.01	1.67	0.33
aorta, adult, pool1	10052-101G7	40.40	0.39	0.78	0.20	107.87	22.75	7.26	4.90
appendix, adult	10189-103D9	43.86	3.88	1.94	0.78	106.73	33.38	11.26	8.93
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	52.62	0.34	0.00	0.00	17.88	9.97	2.06	2.06
artery, adult	10190-103E1	31.25	1.36	1.36	0.00	8.15	10.87	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	87.21	0.29	0.00	0.29	94.74	34.04	16.95	3.91
b cell line:RPMI1788	10427-106D4	31.97	1.19	0.74	0.15	45.50	21.71	2.83	1.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.93	0.00	0.00	0.00	121.24	29.96	7.49	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	88.42	0.60	0.40	0.79	68.67	23.02	6.15	1.69
bile duct carcinoma cell line:TFK-1	10496-107C1	64.44	0.33	0.00	0.67	120.51	29.79	17.91	5.69
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.67	0.56	0.00	0.56	12.86	6.71	1.68	0.00
bladder, adult, pool1	10011-101C2	41.94	0.98	0.76	0.43	53.67	12.06	5.11	3.26
blood, adult, pool1	10053-101G8	101.87	2.21	8.86	2.21	53.15	11.07	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	0.00	1.71	0.00	63.37	17.98	2.57	0.00
bone marrow, adult	10192-103E3	47.91	2.70	0.67	0.00	96.50	31.04	12.15	4.05
brain, adult, donor1	10084-102B3	38.95	1.03	1.03	1.03	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	64.92	0.56	0.78	0.78	6.90	3.01	1.78	0.33
brain, fetal, pool1	10085-102B4	32.06	0.00	0.00	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	134.79	0.66	0.00	0.00	257.68	74.00	20.48	16.52
breast carcinoma cell line:MDA-MB-453	10419-106C5	164.02	0.75	0.12	0.37	43.94	15.60	7.86	4.74
breast, adult, donor1	10080-102A8	29.67	0.63	0.63	0.00	41.04	6.94	1.26	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	56.15	0.00	0.13	0.13	56.40	20.45	4.07	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	66.17	0.31	0.00	0.31	311.08	155.23	140.08	77.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	51.57	0.23	0.00	0.00	285.47	51.80	32.46	11.51
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.20	0.00	0.00	0.00	14.53	5.57	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	57.83	0.00	0.00	0.00	0.47	2.35	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	46.38	0.11	0.00	0.33	19.03	4.92	3.06	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	39.30	0.32	0.00	0.63	20.92	6.34	3.17	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.01	0.80	0.27	0.00	3.73	2.13	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	66.78	2.30	3.45	0.00	66.78	18.42	20.72	14.97
caudate nucleus, adult, donor10252	10164-103B2	54.38	1.84	1.67	1.00	4.85	2.84	1.17	0.50
caudate nucleus, adult, donor10258	10379-105H1	50.43	3.06	0.76	4.58	4.58	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	42.85	0.73	2.20	0.73	58.96	6.96	5.86	5.49
cerebellum - adult, donor10196	10173-103C2	75.75	2.91	2.91	0.00	14.57	2.91	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	79.00	2.56	2.78	0.64	3.20	2.56	0.43	0.43
cerebellum, adult, pool1	10083-102B2	44.15	0.69	0.69	0.00	0.34	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	75.56	4.15	1.66	2.49	12.45	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	58.24	1.76	0.25	1.76	10.09	3.78	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	49.70	0.73	0.00	0.73	64.32	8.77	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	63.98	0.14	0.00	0.00	24.16	9.35	9.35	3.59
cervical cancer cell line:ME-180	10553-107I4	70.93	0.17	0.33	0.17	102.41	23.53	16.24	3.15
cervix, adult, pool1	10013-101C4	48.40	2.10	1.15	0.42	40.95	15.85	7.56	2.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	71.90	0.14	0.70	0.42	90.29	28.84	16.86	5.57
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	1.31	0.00	0.00	5.23	1.31	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	90.72	0.00	0.00	0.00	13.42	4.72	1.74	0.75
choriocarcinoma cell line:SCH	10785-110H2	64.19	0.00	0.00	0.25	12.07	7.15	1.23	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	58.82	0.00	0.00	0.00	3.08	1.42	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	64.11	0.57	0.28	0.00	23.65	10.26	7.12	4.27
chorionic membrane cells, donor2	12239-129G7	108.78	0.00	0.30	0.50	67.02	17.80	19.29	12.03
chorionic membrane cells, donor3	12240-129G8	81.87	0.00	0.00	0.55	28.57	4.95	6.59	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	30.29	1.01	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	33.04	0.19	0.19	0.38	46.87	13.45	1.92	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.11	0.00	0.21	0.63	16.68	6.34	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	45.97	0.00	0.51	0.00	29.02	7.19	0.77	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	47.41	0.48	0.24	0.00	31.20	9.19	0.48	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	49.88	0.41	0.00	0.00	42.35	13.23	1.83	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	68.31	0.59	0.29	0.59	175.79	39.75	8.83	3.83
chronic myelogenous leukemia cell line:KU812	10409-106B4	76.88	0.26	0.00	0.00	51.08	15.90	3.13	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	52.35	0.23	0.46	0.23	160.69	38.63	8.46	2.29
clear cell carcinoma cell line:TEN	10636-108I6	127.18	0.17	0.00	0.17	237.70	51.53	61.25	26.72
colon carcinoma cell line:CACO-2	10513-107D9	123.74	0.55	0.18	0.18	119.89	21.97	24.71	4.58
colon carcinoma cell line:COLO-320	10420-106C6	98.06	0.00	0.00	0.76	1.14	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	57.12	0.00	0.00	0.00	99.96	24.99	3.57	2.38
colon, adult, pool1	10014-101C5	79.08	2.00	1.53	1.06	62.28	22.33	10.81	4.58
colon, fetal, donor1	10070-101I7	35.23	1.85	0.00	0.00	242.25	38.32	6.80	4.94
common myeloid progenitor CMP, donor1	12130-128D6	137.51	4.58	0.00	0.00	13.75	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	25.04	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	56.52	0.85	0.42	0.00	241.36	96.88	17.00	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	39.24	0.45	0.45	0.30	168.29	78.48	9.81	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	49.49	0.85	0.28	0.14	182.75	99.84	13.68	3.38
corpus callosum, adult, pool1	10042-101F6	117.42	1.44	1.33	0.55	9.18	4.31	1.88	0.33
cruciate ligament, donor2	10295-104G7	93.20	4.05	1.62	0.00	128.05	19.45	10.54	4.86
diaphragm, fetal, donor1	10069-101I6	28.09	0.00	0.80	0.00	45.75	11.24	6.42	6.42
diencephalon, adult	10193-103E4	54.00	0.96	0.72	1.20	0.72	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	16.30	1.38	0.69	0.00	4.59	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	42.31	0.51	0.00	0.00	91.04	13.33	19.75	2.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	52.96	0.24	0.00	0.48	110.73	30.81	11.55	2.41
ductus deferens, adult	10196-103E7	53.82	1.00	1.50	0.00	101.66	42.86	17.44	10.96
duodenum, fetal, donor1, tech_rep1	10071-101I8	57.61	0.00	1.44	0.00	188.67	46.09	20.16	15.84
duodenum, fetal, donor1, tech_rep2	10071-101I8	71.36	0.74	1.47	0.74	262.63	67.68	11.03	13.98
dura mater, adult, donor1	10041-101F5	76.48	0.91	1.16	0.41	98.36	34.69	7.68	2.56
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	64.40	0.44	0.67	0.00	20.43	4.22	0.67	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	83.97	0.14	0.29	0.00	5.30	1.00	0.72	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	51.80	0.00	0.62	0.00	31.45	6.78	3.08	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	50.86	0.30	0.30	0.61	66.29	12.41	6.36	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.88	0.00	0.31	0.62	45.69	8.34	6.17	0.93
embryonic pancreas cell line:2C6	10603-108E9	39.40	0.00	0.00	1.31	47.28	6.57	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	54.97	0.34	0.34	0.67	114.30	31.51	25.81	6.70
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	90.07	0.18	0.18	0.00	45.67	11.24	3.81	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	54.35	0.16	0.32	0.48	7.88	1.13	1.45	0.32
epidermoid carcinoma cell line:A431	10426-106D3	59.91	0.22	0.11	0.56	72.59	22.12	18.56	2.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.08	0.22	0.66	1.21	104.05	39.92	9.90	3.30
epididymis, adult	10197-103E8	44.37	0.84	1.26	0.84	78.91	29.51	5.65	2.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.61	0.35	0.00	0.18	174.04	36.72	17.74	2.13
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	58.59	0.79	0.79	1.18	34.61	6.29	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	60.94	0.39	0.66	0.00	80.46	36.82	6.95	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	50.98	0.20	0.10	0.30	101.18	46.65	9.05	5.22
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	62.51	0.34	0.00	0.34	63.86	37.31	6.61	5.60
esophagus, adult, pool1	10015-101C6	38.97	1.06	0.74	0.32	59.35	19.22	6.05	3.93
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	258.99	1.88	2.25	3.13	51.85	26.80	7.76	2.00
eye - muscle inferior rectus, donor1	10272-104E2	84.51	2.41	4.83	9.66	57.95	16.90	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	58.92	2.10	0.00	0.00	42.08	8.42	2.10	4.21
eye - muscle medial, donor2	10299-104H2	46.13	4.46	4.46	0.00	4.46	2.98	1.49	0.00
eye - muscle superior, donor2	10297-104G9	80.25	2.29	2.29	0.00	44.71	8.03	4.59	2.29
eye - vitreous humor, donor1	10268-104D7	40.81	1.46	1.46	0.00	62.67	5.83	5.83	5.83
eye, fetal, donor1	10054-101G9	45.25	0.76	0.25	0.51	48.05	9.41	5.85	2.80
fibrosarcoma cell line:HT-1080	10758-110E2	20.00	0.00	0.00	0.13	42.96	11.16	3.21	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	77.64	0.47	0.47	0.47	117.76	42.26	4.27	2.14
frontal lobe, adult, pool1	10040-101F4	99.45	0.47	0.47	0.66	1.69	1.22	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	117.40	0.00	0.00	0.60	127.01	33.03	22.82	8.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.60	0.09	0.27	0.37	41.05	7.68	7.31	1.46
gall bladder, adult	10198-103E9	48.05	1.45	1.21	0.97	48.29	18.11	2.41	2.66
gamma delta positive T cells, donor1	11937-126A2	40.80	14.50	5.91	2.15	17.18	3.22	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	39.22	11.95	4.48	0.75	9.34	2.61	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.78	0.00	0.21	1.27	35.91	7.82	4.44	2.96
gastric adenocarcinoma cell line:MKN45	10612-108F9	70.02	0.19	0.19	0.39	49.71	5.80	2.32	0.39
gastric cancer cell line:AZ521	10549-107H9	255.44	0.98	2.79	2.62	113.95	42.14	10.49	2.13
gastric cancer cell line:GSS	10560-108A2	63.15	1.83	0.00	0.00	28.37	2.75	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	60.77	0.23	0.23	0.00	4.11	2.74	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	46.81	0.11	0.11	0.23	32.47	6.43	2.29	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	105.39	0.28	0.28	0.70	79.22	32.75	18.89	5.74
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.21	0.25	0.00	0.25	88.54	28.68	7.73	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.24	0.11	0.32	0.21	103.86	27.34	16.78	8.02
glioblastoma cell line:A172, tech_rep2	10444-106F3	53.79	0.28	0.14	0.14	129.20	23.87	24.16	10.53
glioblastoma cell line:T98G	10485-107A8	68.98	0.00	0.00	0.11	160.59	39.73	23.18	12.80
glioma cell line:GI-1	10413-106B8	62.09	0.00	0.88	0.59	17.87	8.20	1.76	1.46
globus pallidus - adult, donor10196	10175-103C4	57.58	1.46	0.73	0.00	40.09	7.29	8.75	2.19
globus pallidus, adult, donor10252	10161-103A8	82.02	1.71	1.71	0.49	14.65	10.01	4.15	1.22
globus pallidus, adult, donor10258	10367-105F7	76.68	1.37	1.37	0.00	5.48	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	25.58	2.66	1.07	0.53	62.88	13.86	7.46	7.99
granulocyte macrophage progenitor, donor1	12131-128D7	90.54	7.34	7.34	14.68	22.02	2.45	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00	5.23	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	35.20	0.00	0.00	0.00	30.72	5.44	3.52	0.96
hIPS +CCl2, biol_rep1	14383-156B9	56.93	0.46	0.46	0.92	16.07	0.92	8.26	1.38
hIPS +CCl2, biol_rep2	14384-156C1	59.44	0.46	0.91	0.00	18.75	2.74	5.03	0.46
hIPS +CCl2, biol_rep3	14385-156C2	37.36	0.00	0.00	0.64	13.53	0.64	7.09	1.29
hIPS, biol_rep1	14380-156B6	45.99	0.00	2.87	2.87	18.68	0.00	14.37	0.00
hIPS, biol_rep2	14381-156B7	38.41	0.00	0.69	0.00	11.66	0.00	3.43	1.37
hIPS, biol_rep3	14382-156B8	66.21	2.21	0.00	1.10	4.41	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	25.29	2.30	0.57	0.57	125.28	44.54	1.15	1.72
heart - mitral valve, adult	10205-103F7	54.41	0.90	1.49	0.00	62.48	31.09	5.38	4.48
heart - pulmonic valve, adult	10206-103F8	33.99	1.57	1.05	0.00	4.97	2.35	1.57	1.31
heart - tricuspid valve, adult	10207-103F9	69.11	2.50	0.83	1.67	107.41	32.47	9.16	7.49
heart, adult, diseased post-infarction, donor1	10050-101G5	43.06	0.82	0.00	0.20	63.87	19.39	4.90	1.63
heart, adult, diseased, donor1	10051-101G6	29.38	0.00	0.43	0.43	34.07	6.81	2.98	2.13
heart, adult, pool1	10016-101C7	29.21	2.76	4.60	0.92	11.96	2.07	1.15	1.15
heart, fetal, pool1	10046-101G1	56.06	2.05	0.92	0.51	66.23	28.03	17.35	9.04
hepatic mesenchymal tumor cell line:LI90	10778-110G4	57.08	0.31	0.31	0.62	128.35	45.66	17.28	8.64
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	0.00	0.00	0.00	3.57	3.57	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	106.08	0.11	0.11	0.33	89.28	46.74	12.15	6.74
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	119.80	0.00	0.00	0.36	94.19	41.39	12.62	6.07
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	114.39	0.30	0.20	0.20	126.42	56.79	17.99	8.99
hepatoma cell line:Li-7	10484-107A7	123.12	0.22	0.78	0.56	111.33	36.81	32.25	13.46
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	38.19	0.20	0.30	0.50	39.30	10.65	2.81	1.61
hippocampus - adult, donor10196	10169-103B7	67.19	2.84	0.00	0.95	21.77	10.41	4.73	0.95
hippocampus, adult, donor10252	10153-102I9	59.39	1.22	2.04	0.61	5.51	2.25	0.61	0.41
hippocampus, adult, donor10258	10374-105G5	47.31	1.49	0.50	1.00	1.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	26.79	1.06	2.47	0.35	38.42	9.87	2.11	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	82.40	0.00	0.61	0.61	142.21	21.97	12.82	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	37.11	0.20	0.20	0.00	44.18	15.90	4.12	4.12
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	44.43	0.00	0.51	0.25	70.33	13.71	5.33	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.68	0.00	0.00	0.00	1.69	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.28	0.00	0.00	0.00	7.75	0.77	0.52	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.72	0.00	0.00	0.38	4.18	1.90	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.12	0.58	0.00	0.00	8.47	1.46	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.48	0.43	0.00	0.00	9.05	4.31	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	0.00	0.00	0.00	16.68	2.50	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	52.33	0.24	0.00	0.00	31.02	5.68	4.97	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	36.32	0.00	0.00	0.00	39.21	11.09	2.09	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	54.54	0.00	0.67	0.00	39.05	2.69	4.04	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.96	0.47	0.16	0.31	53.83	21.91	5.63	6.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	0.00	0.00	0.00	146.41	18.18	16.70	12.28
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	66.33	0.00	0.87	0.00	199.86	27.06	20.07	10.47
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	30.93	0.19	0.19	0.00	6.49	1.53	1.15	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	34.01	0.44	0.44	0.00	6.54	3.05	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	40.48	0.00	0.00	0.00	13.99	2.50	3.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.33	0.00	0.00	0.19	12.25	3.39	0.94	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	29.10	0.00	0.00	0.00	16.37	1.82	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	27.88	0.00	0.31	0.00	11.59	3.45	2.19	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.13	0.16	0.00	0.00	62.71	16.00	3.10	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	36.00	0.00	0.00	0.00	80.42	13.06	2.90	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	30.49	0.00	0.30	0.00	75.63	13.45	4.78	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	40.64	0.18	0.37	0.00	47.11	13.67	6.65	6.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.94	0.29	0.00	0.00	61.34	12.27	7.99	4.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	62.88	0.00	0.00	0.41	80.03	17.15	8.98	11.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	41.55	0.00	0.00	0.00	25.70	2.82	1.06	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	40.54	0.00	0.00	0.00	13.62	3.17	0.95	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	31.17	0.00	0.00	0.00	15.74	4.24	1.21	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.44	0.52	0.00	0.00	6.72	1.55	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	23.25	0.66	0.00	0.00	5.98	5.98	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	33.86	0.00	0.00	0.51	8.47	2.31	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	41.16	0.00	0.00	0.26	102.51	14.32	4.60	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.13	0.00	0.00	0.00	39.38	7.57	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.30	0.00	0.67	0.00	137.11	27.89	9.07	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	36.71	0.24	0.24	0.00	66.41	13.28	7.00	4.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	44.12	0.00	0.00	0.00	100.72	18.72	7.58	9.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.20	0.98	0.00	0.98	67.81	22.93	10.24	7.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.04	0.31	0.00	0.00	4.58	1.83	1.22	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	270.02	0.00	0.00	0.00	45.55	6.51	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	56.92	0.00	0.33	0.00	11.58	4.30	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	0.00	0.00	0.00	13.14	3.83	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	34.02	0.00	0.36	0.00	9.41	1.81	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.81	0.00	0.00	0.00	7.12	2.14	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	0.00	0.00	0.00	95.47	7.16	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.42	0.14	0.00	0.27	79.36	8.80	4.47	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.87	0.00	0.00	0.00	85.94	21.82	4.58	1.62
immature langerhans cells, donor1	11904-125F5	54.97	0.00	0.00	0.24	71.43	7.51	6.30	1.70
immature langerhans cells, donor2	11905-125F6	66.54	0.00	1.58	0.79	83.17	22.97	10.30	3.96
insula, adult, pool1	10039-101F3	98.99	0.85	0.85	0.76	2.08	0.76	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	39.67	0.00	0.00	0.00	7.15	1.95	0.00	0.00
kidney, adult, pool1	10017-101C8	69.29	0.60	0.50	0.40	86.81	28.94	9.31	5.21
kidney, fetal, pool1	10045-101F9	55.67	1.06	0.64	0.35	47.89	16.41	11.53	4.95
large cell lung carcinoma cell line:IA-LM	10509-107D5	75.13	0.43	0.00	0.28	73.85	18.46	12.50	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.98	0.55	0.14	0.14	40.37	9.95	5.67	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	45.14	0.18	0.18	0.00	29.36	11.74	5.32	1.83
left atrium, adult, donor1	10079-102A7	28.33	0.54	0.00	0.00	40.86	7.08	3.27	3.27
left ventricle, adult, donor1	10078-102A6	35.90	1.52	1.01	0.51	7.08	2.02	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	59.65	0.55	0.55	0.27	51.44	14.23	5.75	1.37
leiomyoma cell line:10964C	10569-108B2	31.97	0.00	0.36	0.00	30.18	10.06	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	44.02	0.00	0.00	0.00	36.41	6.52	1.63	0.54
leiomyoma cell line:15425	10571-108B4	36.42	0.00	0.00	0.24	39.58	14.33	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	69.84	19.05	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	120.24	0.00	2.09	1.05	118.15	20.91	6.27	6.27
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	60.33	0.12	0.35	0.24	141.91	48.99	8.97	3.66
liposarcoma cell line:KMLS-1	10782-110G8	55.30	0.31	0.16	0.16	171.83	62.33	22.65	13.75
liposarcoma cell line:SW 872	10726-110A6	46.18	0.12	0.24	0.12	67.62	25.83	6.34	2.31
liver, adult, pool1	10018-101C9	101.13	0.49	0.65	0.16	37.60	12.80	10.86	5.35
liver, fetal, pool1	10086-102B5	49.86	0.00	0.94	0.00	94.07	12.23	6.58	9.41
locus coeruleus - adult, donor10196	10182-103D2	72.33	1.75	2.04	1.17	46.81	16.33	8.75	7.00
locus coeruleus, adult, donor10252	10165-103B3	63.85	2.21	2.21	0.92	10.89	6.27	3.14	1.29
locus coeruleus, adult, donor10258	10375-105G6	40.35	0.85	0.85	1.69	1.41	0.56	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	55.10	1.26	1.68	0.84	99.27	23.55	18.09	8.83
lung adenocarcinoma cell line:A549	10499-107C4	52.31	0.42	0.00	0.00	32.38	7.89	9.96	1.66
lung adenocarcinoma cell line:PC-14	10408-106B3	19.99	0.00	0.00	0.00	29.64	9.65	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	47.72	0.40	0.13	0.13	130.63	27.29	28.60	18.06
lung, adult, pool1	10019-101D1	70.76	4.61	5.79	2.48	47.72	19.73	7.91	3.43
lung, fetal, donor1	10068-101I5	105.60	2.57	0.57	1.14	321.65	20.26	46.52	25.40
lung, right lower lobe, adult, donor1	10075-102A3	45.82	1.37	1.37	1.83	108.60	21.08	6.87	8.71
lymph node, adult, donor1	10077-102A5	32.66	7.10	5.68	0.95	57.28	9.47	3.79	3.79
lymphangiectasia cell line:DS-1	10727-110A7	33.97	0.66	0.22	0.44	20.60	7.01	1.75	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	49.35	2.11	1.06	0.91	135.68	30.34	19.77	12.68
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	0.00	0.00	0.00	244.65	56.07	15.29	0.00
mature adipocyte, donor1	12231-129F8	39.96	3.55	0.89	0.44	148.29	39.07	67.49	21.76
mature adipocyte, donor2	12232-129F9	47.52	3.32	1.66	0.42	122.65	40.68	34.03	14.73
mature adipocyte, donor3	12233-129G1	47.65	1.19	1.42	0.24	189.65	57.13	77.52	36.98
mature adipocyte, donor4	12234-129G2	50.80	2.37	0.53	1.05	156.35	30.27	62.12	27.90
maxillary sinus tumor cell line:HSQ-89	10414-106B9	45.98	0.48	0.00	0.24	67.43	14.53	11.67	3.10
medial frontal gyrus - adult, donor10196	10170-103B8	84.60	1.13	0.00	0.00	18.05	9.02	5.64	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	68.41	1.66	1.84	0.55	5.33	3.68	1.10	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	55.91	0.95	0.00	0.00	0.32	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	118.56	1.71	1.71	1.28	85.30	11.94	7.25	9.81
medial temporal gyrus - adult, donor10196	10183-103D3	61.26	1.35	0.17	0.68	41.34	13.50	4.89	5.57
medial temporal gyrus, adult, donor10252	10156-103A3	71.10	2.12	1.49	0.42	4.67	1.06	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	0.00	0.00	0.00	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	215.30	0.00	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	46.66	0.00	1.08	0.72	30.87	7.18	1.08	1.79
medulla oblongata - adult, donor10196	10174-103C3	75.28	0.00	0.65	0.65	92.80	29.85	20.77	14.93
medulla oblongata, adult, donor10252	10155-103A2	58.98	0.93	1.24	0.31	15.17	7.89	4.64	2.48
medulla oblongata, adult, pool1	10038-101F2	88.48	1.47	1.14	0.90	15.67	6.04	4.00	0.57
medulla oblongata, newborn, donor10223	10361-105F1	38.88	0.35	1.39	1.04	50.34	17.36	13.54	4.86
medulloblastoma cell line:D283 Med	10838-111E1	101.85	0.00	0.22	0.00	0.00	0.89	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	56.86	0.24	0.37	0.12	112.74	27.51	13.82	2.20
melanoma cell line:COLO 679	10514-107E1	60.23	0.14	0.14	0.29	19.26	6.61	3.59	1.01
melanoma cell line:G-361	10465-106H6	65.97	0.27	0.00	0.00	20.09	8.96	1.36	0.54
meningioma cell line:HKBMM	10691-109F7	61.15	0.18	0.18	0.72	45.41	22.79	5.79	3.08
merkel cell carcinoma cell line:MKL-1	10843-111E6	89.88	0.00	0.00	0.88	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	85.28	1.56	0.26	1.04	0.00	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	69.66	0.46	0.31	0.31	134.87	16.57	5.83	2.76
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.45	0.36	0.18	0.36	81.62	8.36	2.91	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	39.75	1.24	0.00	0.41	116.36	8.28	2.90	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.04	0.14	0.70	0.28	89.34	12.36	5.76	2.81
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	47.37	0.39	0.39	0.39	139.61	24.26	10.78	5.97
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	0.69	0.00	2.08	134.65	33.32	8.33	4.86
mesenchymal precursor cell - cardiac, donor1	11752-123G6	45.31	0.51	0.00	0.17	73.97	10.30	2.75	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	35.31	0.12	0.23	0.12	79.02	12.77	3.80	2.19
mesenchymal precursor cell - cardiac, donor3	11754-123G8	57.70	0.00	0.13	0.00	68.04	9.02	5.97	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	72.79	0.27	0.41	0.41	117.08	15.66	4.59	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	79.52	0.43	0.14	0.43	144.68	18.49	7.54	2.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	35.57	0.33	0.00	0.00	45.45	12.52	5.27	2.31
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	57.01	0.00	0.42	0.14	135.88	18.96	14.53	5.26
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	43.98	0.35	0.00	0.00	98.09	24.44	5.93	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	68.80	0.41	0.20	0.20	80.85	11.23	4.70	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	57.87	0.00	0.00	0.36	80.52	24.80	9.71	3.95
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	37.14	0.10	0.00	0.21	85.04	12.72	10.45	5.69
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	36.25	0.23	0.00	0.23	58.82	15.50	5.24	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	93.56	0.42	0.42	0.00	136.78	17.20	7.13	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	63.96	0.15	0.00	0.00	98.78	10.31	10.46	4.33
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	52.87	0.26	0.18	0.35	89.89	15.14	7.00	3.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.40	0.00	0.00	0.37	75.47	19.88	10.31	4.42
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	53.51	0.29	0.29	0.00	111.60	34.05	11.73	4.58
mesenchymal stem cell line:Hu5/E18	10568-108B1	44.21	0.00	0.42	0.00	40.42	14.31	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.16	0.00	0.00	0.91	79.00	7.76	10.50	4.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	37.34	0.77	0.00	0.77	85.18	30.69	9.46	4.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.55	0.79	0.00	0.00	58.11	21.99	6.02	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.96	0.31	0.00	0.62	94.89	33.89	7.70	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.48	0.94	0.00	0.00	95.55	34.60	7.30	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	33.85	0.68	0.68	0.00	84.28	32.15	6.43	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	31.04	0.79	0.39	0.00	88.81	32.62	6.68	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.90	0.00	0.46	0.46	80.17	24.56	3.71	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	193.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	39.22	0.29	0.29	0.29	136.13	41.53	12.40	7.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.61	0.00	0.00	0.00	81.65	24.76	7.59	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.98	0.24	0.48	0.00	96.14	31.01	8.17	2.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	0.73	1.47	1.47	156.20	37.40	5.87	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.55	0.34	0.00	0.34	84.92	30.88	4.36	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	30.70	1.23	1.23	0.00	88.43	25.38	3.28	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	32.22	1.29	0.00	0.43	88.92	22.77	6.01	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	2.73	0.00	155.86	24.61	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	129.12	30.99	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	38.00	0.32	0.00	0.65	103.93	19.16	5.20	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	0.00	0.00	0.00	165.87	33.46	11.64	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	27.72	0.00	0.53	0.00	158.32	26.12	8.53	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	30.26	0.00	0.00	0.82	117.76	20.44	9.00	7.36
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	33.04	0.00	0.00	0.00	114.28	20.99	8.94	6.22
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	0.00	0.00	0.00	153.21	29.38	10.49	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	0.00	0.00	0.99	101.33	21.86	4.97	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00	109.65	28.60	14.30	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.06	0.00	0.00	0.59	106.14	18.38	9.49	8.30
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	0.00	0.00	1.22	115.75	19.50	13.40	10.97
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	36.74	1.90	1.27	0.00	107.04	13.93	11.40	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.87	0.34	0.69	0.34	69.67	10.35	10.35	7.24
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	0.00	0.00	0.00	81.67	23.64	6.45	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	0.00	0.00	103.79	31.93	0.00	15.97
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	0.00	0.00	34.44	30.99	13.78	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.08	0.00	0.00	0.41	35.04	12.63	7.33	4.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	0.00	0.00	0.00	70.71	19.86	8.74	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	32.42	0.00	0.00	0.59	25.35	11.20	6.48	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	0.31	0.31	0.31	24.62	11.22	5.92	5.30
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	1.34	1.34	0.00	28.07	16.04	12.03	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	1.18	0.00	0.00	18.92	4.73	3.55	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	2.57	0.00	0.00	20.54	12.84	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.98	0.00	0.00	2.75	12.39	6.88	4.13	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	36.62	0.00	0.00	0.00	4.95	0.49	1.98	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	0.00	0.00	0.00	4.49	0.00	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	42.62	0.00	0.64	0.64	1.91	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	33.85	0.00	0.00	0.00	4.84	1.21	1.21	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	74.14	2.18	0.00	0.00	10.90	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	2.53	0.00	0.00	11.40	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	0.61	0.00	0.61	8.50	1.82	2.43	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	0.00	18.08	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	0.82	0.00	0.00	10.71	4.94	3.29	4.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.92	0.20	0.40	0.00	17.06	4.17	6.75	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.48	0.65	0.00	0.97	13.30	2.92	1.62	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	0.00	0.00	0.00	10.19	3.06	4.07	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	0.00	0.00	0.00	44.10	7.74	9.28	5.42
mesothelioma cell line:ACC-MESO-1	10493-107B7	34.02	0.00	0.24	0.24	87.88	18.19	9.69	4.02
mesothelioma cell line:ACC-MESO-4	10494-107B8	37.76	0.00	0.00	0.46	32.90	7.88	2.78	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	0.00	0.00	4.27	200.86	68.38	38.46	34.19
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	83.64	0.21	0.31	0.00	213.62	30.72	44.70	31.54
mesothelioma cell line:Mero-25	10850-111F4	30.64	0.00	0.23	0.23	78.98	16.79	3.40	2.27
mesothelioma cell line:Mero-41	10851-111F5	44.74	0.00	0.00	0.00	97.06	25.18	7.33	3.91
mesothelioma cell line:Mero-48a	10852-111F6	66.43	0.00	0.00	0.44	180.02	38.31	18.60	10.41
mesothelioma cell line:Mero-82	10853-111F7	37.32	0.00	0.00	0.26	96.98	29.96	11.04	6.31
mesothelioma cell line:Mero-83	10854-111F8	86.64	0.34	0.00	0.68	232.69	57.70	47.49	30.30
mesothelioma cell line:Mero-84	10855-111F9	89.48	0.25	0.25	1.52	152.17	36.40	25.28	10.87
mesothelioma cell line:Mero-95	10856-111G1	38.30	0.41	0.00	0.00	120.50	20.70	22.15	10.56
mesothelioma cell line:NCI-H2052	10847-111F1	42.57	0.17	0.17	0.50	73.22	17.06	2.65	1.33
mesothelioma cell line:NCI-H226	10846-111E9	21.72	0.18	0.00	0.00	40.54	13.76	2.53	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	48.51	0.17	0.17	0.51	122.14	32.63	7.52	4.78
mesothelioma cell line:NCI-H28	10845-111E8	61.58	0.51	0.00	0.76	263.12	58.27	15.52	11.96
mesothelioma cell line:No36	10857-111G2	45.02	0.65	0.00	0.33	62.63	17.29	12.72	4.89
mesothelioma cell line:ONE58	10858-111G3	69.36	0.00	0.00	0.81	121.93	18.70	12.73	7.86
migratory langerhans cells, donor1	11901-125F2	53.16	0.77	0.19	0.00	99.42	7.48	3.26	0.77
migratory langerhans cells, donor2	11902-125F3	45.43	0.73	0.24	0.24	55.56	4.40	2.44	0.24
migratory langerhans cells, donor3	11903-125F4	45.41	0.72	0.00	0.00	58.87	5.20	2.33	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.30	0.00	0.33	0.65	18.61	5.22	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.87	0.21	0.21	0.64	181.63	43.66	47.05	26.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.36	0.23	0.00	0.69	49.53	14.28	1.15	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	26.83	0.38	0.38	0.95	132.63	59.75	6.09	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.62	0.55	0.18	0.74	0.74	0.74	0.37	0.18
myeloma cell line:PCM6	10474-106I6	44.48	1.58	0.99	0.59	99.82	31.82	15.22	5.53
myxofibrosarcoma cell line:MFH-ino	10600-108E6	35.51	0.51	0.00	0.00	53.77	9.64	3.04	3.55
myxofibrosarcoma cell line:NMFH-1	10684-109E9	61.98	0.00	0.78	0.39	120.63	32.17	4.71	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	51.81	0.11	0.33	0.22	35.32	10.25	4.35	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	51.18	0.29	0.22	0.07	56.11	15.66	6.25	3.46
nasal epithelial cells, donor2	12227-129F4	49.68	0.00	0.00	0.00	18.22	4.42	3.86	0.55
neuroblastoma cell line:CHP-134	10508-107D4	133.67	2.30	0.46	0.23	0.23	0.46	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	96.35	2.06	0.75	0.75	3.37	1.12	1.12	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	70.65	0.00	0.00	0.21	11.81	1.90	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	89.82	0.19	0.00	0.56	2.42	2.05	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.33	0.95	0.00	0.00	5.46	2.61	0.47	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.86	0.16	0.00	0.16	95.82	28.03	9.66	6.02
neuroectodermal tumor cell line:TASK1	10774-110F9	41.26	0.40	0.00	0.20	0.81	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	48.32	0.00	0.00	1.27	1.91	1.27	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	35.13	0.00	0.00	0.00	84.37	18.90	5.06	2.13
neutrophil PMN, donor1	12133-128D9	14.87	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	39.84	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	9.47	9.47	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	71.54	9.47	4.23	3.38	0.00	0.51	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	148.09	2.40	0.00	0.00	6.40	4.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.87	0.32	0.00	0.00	39.11	12.50	7.69	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	46.77	0.00	0.26	0.26	77.25	35.47	3.94	3.68
nucleus accumbens, adult, pool1	10037-101F1	92.90	1.41	0.94	1.59	3.47	1.59	1.03	0.19
occipital cortex - adult, donor10196	10172-103C1	78.29	4.12	0.00	0.00	26.78	4.12	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	77.56	3.22	2.15	0.81	7.78	4.56	1.07	0.27
occipital cortex, newborn, donor10223	10355-105E4	47.31	1.46	0.73	0.73	25.48	2.91	1.46	1.46
occipital lobe, adult, donor1	10076-102A4	72.42	0.79	0.52	0.79	2.89	1.57	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	70.80	0.86	0.43	0.00	6.44	1.72	0.00	0.00
occipital pole, adult, pool1	10036-101E9	66.86	0.79	0.71	1.10	0.79	0.32	0.00	0.08
olfactory region, adult	10195-103E6	50.06	0.19	0.57	0.00	3.06	0.76	0.38	0.00
optic nerve, donor1	10277-104E7	104.05	2.00	0.00	2.00	34.02	12.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	50.69	0.00	0.11	0.00	53.54	22.21	6.83	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	132.58	0.27	0.41	0.14	100.29	22.26	15.39	3.85
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.54	0.17	0.00	0.00	63.33	16.93	6.26	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	33.96	0.12	0.12	0.12	239.80	63.18	27.03	7.39
osteoclastoma cell line:Hs 706.T	10704-109H2	32.63	0.29	0.00	0.00	30.28	10.58	2.35	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.96	0.93	0.00	0.00	108.38	17.75	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	51.53	0.00	0.21	0.00	7.42	1.48	4.03	0.85
ovary, adult, pool1	10020-101D2	45.95	1.14	1.22	0.79	31.80	10.05	4.89	1.75
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	43.63	0.37	0.55	0.18	80.29	27.31	5.87	1.28
pancreas, adult, donor1	10049-101G4	64.90	0.00	0.00	0.00	131.69	50.79	15.99	15.05
pancreatic carcinoma cell line:NOR-P1	10698-109G5	47.52	0.00	0.00	0.00	6.71	2.80	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	53.49	0.00	0.17	0.17	179.04	58.77	10.22	6.47
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	193.23	0.50	1.49	1.82	206.48	42.89	46.03	13.08
paracentral gyrus, adult, pool1	10035-101E8	99.48	0.92	0.55	0.64	2.01	0.82	0.37	0.37
parietal cortex, adult, donor10258	10373-105G4	63.86	0.00	1.47	1.47	2.20	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	70.54	4.70	0.00	0.00	20.69	5.64	3.76	2.82
parietal lobe, adult, donor10252	10157-103A4	69.26	1.71	0.57	0.57	6.84	3.71	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	97.55	1.15	1.32	1.06	2.38	0.88	0.44	0.18
parietal lobe, fetal, donor1	10072-101I9	73.71	1.94	0.00	0.00	4.85	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	59.82	1.12	1.50	0.75	47.48	8.97	2.62	1.50
parotid gland, adult	10199-103F1	30.83	1.23	0.62	0.00	3.08	1.23	1.23	0.62
penis, adult	10200-103F2	35.45	1.61	0.00	0.54	44.04	27.39	2.69	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	44.07	0.37	0.19	0.00	33.84	10.97	4.65	3.53
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	66.44	0.00	0.44	0.00	142.78	66.15	36.86	10.49
pineal gland - adult, donor10196	10179-103C8	83.21	1.29	0.00	1.29	32.90	7.10	6.45	1.29
pineal gland, adult, donor10252	10160-103A7	95.35	0.00	1.18	0.59	14.21	3.55	5.33	1.78
pineal gland, adult, donor10258	10377-105G8	52.67	0.00	0.63	1.25	3.14	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	116.36	2.02	1.01	0.00	42.50	17.20	11.13	7.08
pituitary gland, adult, donor10252	10162-103A9	124.56	1.04	1.04	0.00	32.83	13.55	6.78	5.21
pituitary gland, adult, donor10258	10378-105G9	57.88	0.00	0.00	0.00	14.47	2.55	1.70	1.70
placenta, adult, pool1	10021-101D3	77.94	0.97	0.97	0.22	20.10	6.02	5.16	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	43.04	2.25	1.85	1.19	78.66	19.07	4.77	3.05
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	76.42	0.93	0.62	0.62	106.77	21.95	23.66	14.63
pons, adult, pool1	10033-101E6	98.03	0.77	0.86	1.38	3.87	2.50	1.55	0.60
postcentral gyrus, adult, pool1	10032-101E5	81.94	0.61	0.26	0.87	0.87	0.52	0.09	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	12.55	4.18	16.73	4.18	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00	5.51	0.00	5.51	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	80.99	0.29	0.44	0.87	186.30	58.99	35.69	14.71
prostate cancer cell line:PC-3	10439-106E7	123.42	1.09	0.54	0.73	273.16	52.82	26.14	3.09
prostate, adult, pool1	10022-101D4	45.98	1.72	1.09	0.45	39.45	15.51	8.53	2.99
putamen, adult, donor10196	10176-103C5	70.35	3.07	1.65	1.89	12.51	5.90	2.36	1.65
putamen, adult, donor10252	10152-102I8	54.90	0.00	5.88	5.88	9.80	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	0.00	0.00	0.00	10.93	3.28	5.46	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	48.81	1.21	0.97	0.97	2.17	0.48	0.24	0.24
putamen, newborn, donor10223	10365-105F5	75.72	1.50	2.25	0.75	120.70	33.73	26.99	28.49
rectal cancer cell line:TT1TKB	10469-106I1	37.24	0.29	0.00	0.29	138.78	34.91	32.29	9.60
rectum, fetal, donor1	10067-101I4	72.33	1.39	1.39	0.00	45.90	15.30	5.56	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.94	0.00	0.00	0.42	48.12	16.96	6.57	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	52.60	0.00	0.00	0.00	81.60	19.47	4.56	0.83
retina, adult, pool1	10030-101E3	77.03	0.99	1.19	0.50	35.19	13.82	5.77	2.19
retinoblastoma cell line:Y79	10475-106I7	74.56	0.26	0.00	0.00	0.26	1.04	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.56	0.12	0.12	0.00	26.68	11.93	4.06	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	86.89	1.12	1.12	0.28	2.53	0.56	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	0.00	0.00	0.00	21.98	2.27	0.00	0.00
salivary acinar cells, donor1	11771-123I7	36.90	0.16	0.00	0.32	29.46	7.12	2.75	2.10
salivary acinar cells, donor2	11772-123I8	33.73	0.28	0.00	0.00	44.61	12.67	2.75	3.44
salivary acinar cells, donor3	11773-123I9	39.06	0.00	0.00	0.66	45.68	13.90	1.99	0.00
salivary gland, adult, pool1	10093-102C3	66.92	1.14	0.00	0.00	21.16	0.57	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.50	0.08	0.00	0.08	38.11	10.71	3.12	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.51	0.12	0.00	0.00	40.67	9.64	2.35	0.71
seminal vesicle, adult	10201-103F3	44.97	1.59	0.53	0.00	96.82	43.91	6.35	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	60.49	0.24	0.00	0.24	432.65	115.15	88.67	84.78
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	86.31	1.01	0.25	0.75	28.94	6.29	3.52	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	85.30	1.00	3.01	1.00	320.13	54.19	8.03	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	58.97	0.40	0.27	0.40	59.24	34.79	5.78	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	77.04	0.22	0.22	0.22	46.97	14.04	1.11	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	283.08	1.29	0.77	1.29	271.47	47.48	10.84	4.52
skeletal muscle - soleus muscle, donor1	10282-104F3	51.07	1.42	0.71	0.71	4.26	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	35.38	1.56	0.60	0.48	8.04	3.00	1.44	0.72
skeletal muscle, fetal, donor1	10066-101I3	12.06	0.00	0.00	0.00	23.12	4.02	1.01	1.01
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	58.07	3.16	0.63	0.00	85.22	27.77	7.57	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	69.04	0.00	0.67	0.67	4.00	2.33	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	64.93	0.32	0.32	0.63	0.00	0.00	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	135.50	0.00	0.19	0.39	32.77	6.55	1.73	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	79.12	0.00	0.16	0.33	18.79	3.13	1.15	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	83.16	0.00	0.16	0.00	0.16	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.20	0.22	0.22	0.00	19.18	4.58	1.53	1.31
small intestine, adult, pool1	10024-101D6	145.84	3.11	2.03	1.31	101.77	42.04	23.65	7.52
small intestine, fetal, donor1	10064-101I1	65.11	1.23	0.25	0.00	148.65	32.43	9.09	6.63
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	41.03	0.00	0.00	0.51	15.39	4.62	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	36.96	0.52	1.03	0.26	103.12	21.45	13.18	12.66
somatostatinoma cell line:QGP-1	10781-110G7	64.59	0.27	0.27	0.54	19.57	5.36	0.80	1.07
spinal cord - adult, donor10196	10181-103D1	73.18	0.23	0.92	0.69	108.74	22.48	9.41	13.76
spinal cord, adult, donor10252	10159-103A6	60.32	1.97	3.55	1.18	52.04	15.38	18.14	3.94
spinal cord, adult, donor10258	10369-105F9	65.72	1.38	1.38	0.00	17.29	2.77	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	71.35	1.83	1.83	0.61	60.37	16.47	4.88	3.05
spinal cord, newborn, donor10223	10359-105E8	87.25	0.92	3.67	1.84	84.50	16.07	11.94	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.55	0.15	0.15	0.00	34.80	7.77	1.34	0.00
spleen, adult, pool1	10025-101D7	91.85	6.06	7.27	2.86	42.18	18.06	13.77	6.39
spleen, fetal, pool1	10044-101F8	69.84	4.37	3.02	1.35	105.52	55.86	51.33	27.97
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	42.13	1.14	0.52	0.41	46.68	13.97	3.52	1.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	55.06	0.19	0.57	0.19	110.51	22.03	21.46	4.56
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	61.15	0.00	0.70	0.35	92.95	19.92	10.83	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.13	0.39	0.00	0.39	89.52	12.12	1.95	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	85.77	0.11	0.11	0.45	136.76	36.58	15.65	5.07
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	74.98	0.00	0.00	0.42	58.03	5.08	3.39	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.77	0.00	0.42	0.00	27.08	2.12	2.12	1.69
stomach, fetal, donor1	10062-101H8	70.49	0.00	0.00	2.14	169.81	39.52	5.34	3.20
submaxillary gland, adult	10202-103F4	40.45	1.14	2.28	0.57	15.38	1.71	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	54.27	0.00	1899.60	759.84	217.10	54.27
substantia nigra, adult, donor10252	10158-103A5	67.30	2.08	2.08	0.83	15.99	8.93	2.08	1.04
substantia nigra, adult, donor10258	10371-105G2	57.93	3.62	0.52	2.07	1.03	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	36.74	0.71	1.41	0.00	93.27	11.31	9.89	7.77
synovial sarcoma cell line:HS-SY-II	10441-106E9	129.08	1.60	1.38	2.29	39.66	12.15	6.42	2.52
temporal lobe, adult, pool1	10031-101E4	63.07	0.42	0.42	0.42	1.44	0.76	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	73.36	0.71	0.71	0.71	0.71	2.85	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.47	0.00	0.00	0.44	5.27	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	47.83	0.35	0.35	0.35	79.94	30.02	8.38	7.68
tenocyte, donor2	11765-123I1	34.34	0.76	0.00	0.38	119.79	41.20	14.88	6.49
tenocyte, donor3	11768-123I4	39.29	0.74	0.37	0.37	74.50	11.86	5.56	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	109.79	0.51	0.17	0.17	28.38	7.65	2.89	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	51.02	0.15	0.15	0.00	0.31	0.62	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	52.07	0.62	0.00	0.00	5.42	3.41	0.93	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.59	0.51	0.51	0.38	19.17	8.00	1.90	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	67.69	0.00	0.38	0.00	11.35	3.78	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	53.88	0.22	0.00	0.11	7.63	1.20	1.85	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.70	0.00	0.00	0.33	15.63	3.26	0.33	0.00
testis, adult, pool1	10026-101D8	80.53	1.61	1.50	0.86	20.40	7.30	2.90	2.47
testis, adult, pool2	10096-102C6	88.41	0.90	0.90	0.45	22.55	4.51	1.80	1.35
thalamus - adult, donor10196	10168-103B6	73.97	1.10	3.31	5.52	50.78	9.94	14.35	5.52
thalamus, adult, donor10252	10154-103A1	63.14	2.19	2.03	0.47	8.75	5.16	1.72	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	67.74	0.00	0.00	1.54	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.04	0.49	0.33	0.16	2.31	0.33	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	49.48	0.00	2.30	1.73	52.93	10.93	8.05	6.90
throat, adult	10209-103G2	35.95	2.00	1.75	0.75	62.67	18.73	3.99	2.75
throat, fetal, donor1	10061-101H7	40.83	2.13	0.91	1.83	90.19	17.37	8.84	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	48.09	0.00	0.00	0.60	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	40.96	4.87	1.99	1.29	9.44	2.19	1.19	0.99
thymus, fetal, pool1	10043-101F7	66.81	3.53	2.29	0.94	38.03	19.33	8.31	3.84
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.88	0.13	0.27	0.40	239.86	32.71	12.63	4.52
thyroid carcinoma cell line:TCO-1	10783-110G9	32.83	0.00	0.00	0.00	142.62	50.01	14.81	7.26
thyroid, adult, pool1	10028-101E1	59.44	1.03	0.56	0.19	11.10	5.60	2.89	1.21
thyroid, fetal, donor1	10060-101H6	61.96	1.05	0.00	0.26	109.42	36.91	15.56	8.70
tongue epidermis (fungiform papillae), donor1	10288-104F9	101.63	9.24	0.00	3.08	43.11	0.00	0.00	0.00
tongue, adult	10203-103F5	33.26	0.70	0.47	0.70	48.38	16.05	1.40	3.49
tongue, fetal, donor1	10059-101H5	28.77	1.18	0.39	1.18	30.74	5.52	2.36	1.58
tonsil, adult, pool1	10047-101G2	57.00	4.21	1.70	1.70	97.87	30.85	15.43	6.41
trachea, adult, pool1	10029-101E2	51.78	2.04	1.88	0.74	98.89	29.45	14.31	6.71
trachea, fetal, donor1	10058-101H4	37.70	2.69	0.38	0.38	116.56	26.16	7.69	5.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.06	0.35	0.00	0.00	29.76	11.69	2.13	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	85.71	0.71	0.81	0.10	145.09	37.59	16.21	3.85
transitional-cell carcinoma cell line:JMSU1	10492-107B6	61.89	0.00	0.00	0.00	128.95	33.84	18.02	5.17
tridermal teratoma cell line:HGRT	10694-109G1	43.76	0.00	0.00	0.00	22.83	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	135.78	0.25	0.85	0.93	155.08	44.36	17.69	3.72
umbilical cord, fetal, donor1	10057-101H3	45.90	0.00	0.00	0.00	73.03	20.87	8.35	8.35
uterus, adult, pool1	10100-102D1	70.47	2.22	0.51	0.68	59.04	7.00	13.14	5.46
uterus, fetal, donor1	10055-101H1	50.17	0.51	1.02	0.51	72.69	15.87	8.19	3.58
vagina, adult	10204-103F6	34.89	3.88	1.29	1.94	13.57	8.40	0.00	4.52
vein, adult	10191-103E2	29.81	4.38	1.75	0.66	24.33	10.52	1.75	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	24.57	0.27	0.00	0.27	30.71	7.74	1.60	0.53

Property "Nearest transcripts" (as page type) with input value "ENST00000591315.5:-246 ENST00000592106.5:-258 ENST00000589823.6:-268 ENST00000588131.1:-293 AF214006:-296 AK294854:-299 ENST00000587945.1:-300 ENST00000262291.9:-310 NM_001329402.2:-310 NM_001329400.2:-310 NM_001329401.2:-310 NM_001329399.2:-310 NM_001329398.2:-310 NM_001329396.2:-310 NM_001329397.2:-310 NM_030938.5:-310 NM_001329395.2:-310 NM_001329394.2:-310 AK024969:-312 ENST00000585847.5:-313 BC009758:-313 ENST00000586245.5:-314 AK301254:-314 ENST00000593168.5:-316 AK293578:-316 AL136711:-322" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.